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 The recent prevalence of ultrasonography has facilitated the early 
detection and qualitative evaluation of thyroid nodules – to differentiate 
between thyroid carcinoma and benign nodule, between metastatic lymph node 
and reactive node. It has moved from the suite of the radiologist to the 
surgeon’s office. The aim of the present study was to evaluate the relevance of 
SPUS in the diagnosis and surveillance of malignancy of the thyroid. 
Methods 
 Surgeon performed ultrasound for 389 patients and the data of 350 
patients who underwent total thyroidectomy was compared with the report of 
the RPUS, FNAC and HPE. The sensitivity, specificity, positive predictive 
value, negative predictive value for each was calculated. The nodule 
characteristics – echogenicity, margins and calcifications were analysed for 
correlation with malignancy. 
Conclusions 
 Surgeon who is more familiar with the anatomy and patho-physiology of 
thyroid disorders triages the nodule better. Multivariate analysis of nodule 
characteristics showed that heteroechogenicity, irregular margins and 
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 Most of the patients attending the outpatient ward of Endocrine Surgery 
Department present with nodular goiter. Of this 90% of the cases are benign. It 
is essential for the Endocrine Surgeon to identify the remaining 10% of the 
malignant cases at an early stage.29 so that they can be managed appropriately 
with reduced morbidity. 
 Clinical symptoms of hoarseness of voice, pressure effects and signs of 
fixity appear much later. FNAC is an useful clinical adjunct distinguishing the 
benign goiters from the malignant ones, misses malignancy in about a third of 
the lesion57 and the negative predictive value is never a 100%. Ultrasonogram 
is an extension of the clinician’s arms and the shadows cast help in 
distinguishing the benign nodules from the malignant ones.34 Moreover it is 
quick, painless, inexpensive, reproducible and safe to all patients without any 
radiation hazard. It can also be combined with FNAC to improve the diagnostic 
accuracy67. However the interpretation of images is operator dependent. Apart 
from this, it is also useful in assessing the regional lymph nodes which is 
important for determining the extent of lymph node dissection and evaluating 
the biologic behavior including prognosis. 
 When a surgeon, who is more acquainted with the anatomy of the  
neck56 performs an ultrasound, obtains more real time information from the 
images, which helps in making accurate management decisions and saves the 
patients effort and time in approaching another consultant. 
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 The objective of this study is to evaluate the effectiveness of 
ultrasonogram in identifying malignancy of the thyroid for its early and 




REVIEW OF BASIC SCIENCES 
Evolution of Ultrasound 
 The roots of sonography can be traced back to the ancient Greeks. 
Pythagoras invented the sonometer which was used to study musical sounds. 
Boethius was the first to compare sound waves produced by dropping a pebble 
into water. 
 Ultrasound was conceived in 1877, when the French Physicist Pierre 
Curie discovered Piezo electric effect. The sinking of the Titanic on its maiden 
voyage in 1912 made people want to know how to detect submerged objects. 
Constantin Chilowsky came up with the idea for an ultrasonic detection system, 
which was brought to the notice of the French government. As instructed by the 
French government, Paul Langevin, student of the Curie brothers, used the 
Piezo electric effect and invented the SONAR in 1917. 
 Soviet Physicist Sergei Sokolov used ultrasound for industrial purposes 
including detection of flaws in metals. 
 In 1920’s and 30’s ultrasound was used for physical therapy, for 
sterilization of vaccines and for cancer therapy in combination with radiation 
therapy. 
 Karl Dussik, a neurologist in Austria is the first physician to employ 
ultrasound in medical diagnosis in 1940’s. He along with his brother used 
‘hyperphonography’ to locate brain tumours and cerebral ventricles. Later 
George Ludwig used ultrasound to detect gallstones. 
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 Douglas Howry a radiologist, concentrated on the development of B-
mode equipment that compared cross sectional anatomy to gross pathology in 
1948. In 1950 John Reid and John Wild built a linear hand held B-mode 
instrument. For breast tumours Joseph Holmes in 1951, produced the first 2D 
B-mode linear compound scanner. 
 Wolf Keidel, Inge Edler and Hellmuth Hertz of Sweden are considered 
the Fathers of echocardiography. In 1956, Robert Rushmer a physiologist along 
with two engineers Dean Franklin and Don Baker led to the development of 
continuous wave Doppler. 
 The late 60’s and early 70’s is referred to as the sonic boom. During this 
period 2D echo was introduced by Klaus Bom. Real-time ultrasound started to 
appear in the early 1980. In the 1990’s the field went one step further with 3D 
and 4D images. 
 In the early days scanning equipment was very large. The invention of 
the transistor and integrated circuitry made it possible to build smaller and 





Historical perspective of thyroid ultrasound 
 Sonography commands a central role in the evaluation, diagnosis and 
treatment of thyroid disorders. The initial use came at a time when palpable 
thyroid nodules were surgically excised to establish a pathologic diagnosis. In 
the late 1960’s USG was used to differentiate between solid and cystic nodules 
and to measure and track nodule size.58 The first use of ultrasound to examine 
the thyroid grand was by Yamakawa and Naito in 1966 to calculate thyroid 
volume and weight. Then Fujimoto used to study structural alterations in the 
gland. This was before the advent of the high frequency probe when a water 
bath technique was used – enough water was used to permit the thyroid tissue 
to fall within the focal range of the transducer – probably 3 to 6 cm. 
Subsequently commercially available polymer pads were used to reduce the 
reverberation artifacts in a water bath, in the stand off technique. With the 
availability of high frequency probes and high viscosity couplants, the direct 
contact technique has come into vogue. 
 Using conventional ultrasonography clinicians were able to differentiate 
between cysts and cystic degeneration in an adenoma, solitary nodules from 
multinodular goiters and to detect the presence of thyroiditis with greater than 
90% accuracy47. 
 Later investigators began studying whether they could improve surgical 
and medical decision making by identifying malignant features of thyroid 
lesions.31 The role of thyroid ultrasound has continued to expand over the past 
40 years and is currently recommended in the evaluation of all palpable 
nodules by the American Thyroid Association (ATA). The American 
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Association of Clinical Endocrinologists (AACE) and the Association Medici 
Endocrinologi (AME).10,16 
 Advances in ultrasound engineering and electronic technology in the 
1990s has made ultrasound more user friendly. Ultrasound which was once in 
the purview of the sonographers, who took spot films that were interpreted by 
the radiologist for the clinician has now moved into the office of the surgeon, 
who takes history, examines the patient and allows ultrasound findings to be 
integrated with the patients clinical findings. This cuts the cost of the patient 
going to another specialist and provides valuable real time information to the 
surgeon who appreciates even subtle changes in suspected malignancy. 
 The recent introduction of small linear phased-array transducers greatly 
facilitates USG guided FNAB that decreases the number of inadequate 
biopsies. 
Future Use of Ultrasound33 
 Ultrasonography is uniquely portable when compared to CT and MRI, 
does not carry the risk of irradiation, making it ideal for use in clinical setting. 
 Laptop sized and palm sized sonograms with better resolution will allow 
the increased use of ultrasound in the clinical sitting. Objective palpation by 
elastography will prove to be useful in determining whether a lesion is benign 
or malignant. Combining this technique with the study of vascular detail using 




 The promise of coagulating bleeders with HIFU has great appeal and is 
yet to be perfected. Targeted microbubble delivery of drugs and DNA plasmids 
with ultrasound’s ability to increase cell penetration holds great promise for the 
therapeutic use of ultrasound. 
Basic Physics of Ultrasound 
 Audible sound waves lie between 20 and 20,000 Hz. Ultrasound uses 
sound waves with a greater frequency 1 to 30 MHz. Sound waves need a 
medium to get propagated. The closer the molecules, the faster the sound wave 
moves through the medium, so bone and metals conduct sound waves well. Air 
in lung and bowel conduct poorly. Gel or mineral oil must fill the space 
between the transducer and the patient, otherwise sound will not be transmitted 
across this gap. 
 Ultrasonogram utilises the Piezo electric effect and the Pulse-Echo 
principle. When a crystal like quartz or lead zirconate is electrically stimulated. 
It changes shape and vibrates thus producing a sound beam that propagates 
through tissues. The crystal emits the sound wave and then waits for the 
returning echo reflected from the structures in the plane of the sound beam. 
When the echo is received, the crystal again vibrates, generating an electrical 
voltage comparable to the strength of the returning echo. 
 B-mode is a method of displaying the intensity of an echo by varying 
the brightness of a dot to correspond to echo strength. Hyperechoic structures 
appear brighter and hypoechoic tissues are darker than surrounding tissues. 
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 The strength of the returning echo is related to the angle at which the 
beam strikes the acoustic interface. The more perpendicular, the stronger the 
echo. Acoustic impedance relates to tissue density, the greater the difference in 
density between two structures, the stronger the returning echo. 
 Transducer frequencies vary between 2.5, 3.5, 5 and 7 MHz. Increasing 
the frequency improves resolution but decreases penetration. The thyroid can 
be imaged using a 7.5 to 15 MHz probe. The waves close to the skin the 
Fresnel Zone suffers from the effect of turbulence and resolution here is poor. 
Beyond the focal zone, the beam widens – Fraunhofer zone where the images 
are distorted and difficult to see. 
 Sound waves can be scattered where they do not return to the detector. 
Reflectors fall into 2 categories. (1) Specular (2) Diffuse. Specular reflector 
acts like a mirror.9 It is smooth and large compared to the wavelength of the 
sound wave. Examples include carotid artery and fluid filled cysts. Diffuse 
reflectors account for speckled patterns. Sound energy is scattered rather than 
reflected in coherent manner when the wavelength of sound wave is larger than 
the size of the reflector. 
 Diagnostic imaging relies on the return of sound wave energy to the 
transducer. In addition to the scattering that occurs with diffuse reflectors and 
the angled reflectance, caused by specular reflectors, another major source of 
energy loss is attenuation. Absorbance of the sound energy along the path of 
the wave limits the potential depth of penetration. Tissues absorb sound energy 
by converting the sound energy into heat. This conversion increases with the 
frequency of the sound wave and becomes the major factor limiting the depth 
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of tissue penetration when using higher ultrasonic frequencies. Resolution sets 
the lower limit on the useful range of ultrasound frequencies for the head and 
neck region. Absorbance, the chief cause of attenuation, sets the upper limit. 
The Physics of Artifacts 
 Reverberation, multipath, shadowing, enhancement, side lobe and 
refraction are the most common artifacts in B-mode ultrasound. 
 Reverberation artifacts occur when the sound waves repeatedly reflect 
between two interfaces with significantly mismatched impedences. This 
commonly occurs at the tracheal rings. The anterior soft tissue to cartilage 
interface and the posterior cartilage to air interface lead to serial reflections 
with a resulting artifactual increase in apparent path length. 
 Multipath artifacts occur at specular reflectors altering the apparent 
position and shape of objects. The small specular reflectors such as carotid 
artery, rarely lead to multipath artifacts. Shadowing artifacts are due to 
attenuation of sound energy leading to little or no reflections being returned 
from deeper objects because of lack of sound energy. This can be due to thick 
muscles or calcifications in the thyroid. 
 Enhancement can occur when attenuation of overlying  tissues is less 
than surrounding tissues. For example fluid filled cysts and blood within blood 
vessels have lower attenuation than surrounding soft tissues leading to 
enhancement of deeper tissues. 
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 Side lobe artifacts arise when there are strong reflectors just outside the 
primary beam path. Reflection off a cyst wall outside the sonographic plane 
can make it appear that there is a mass within the cyst. 
 Refraction artifacts occur when there is a change in direction of 
propagation when a sound wave passes between two media with different 
propagation velocities. This moves the position of the object resulting in 
spurious duplicates and can occur at muscle edges. 
Thyroid ultrasonography goals and indications36 
• To better assess palpable thyroid nodules. 
• To determine whether nodularity is present in the patient with an 
equivocal or difficult physical examination. 
• To determine whether characteristics associated with malignancy are 
present. 
• To screen for thyroid lesions in patients with other diseases in the neck, 
such as hyperparathyroidism, who are undergoing treatment planning. 
• To assess the thyroid and the extra thyroid neck in the patient with 
thyroid cancer before treatment. To identify thyroid features associated 
with diseases including thyroiditis and Graves disease. 
• To help teach regional anatomy and the art of thyroid palpation. 
• To monitor foetal thyroid development in utero. 
• To detect goiter as a sign of iodine deficiency. 




• To facilitate FNA biopsy of a nodule. To assess the remainder of the 
thyroid gland in the patient with a palpable thyroid nodule. 
• To screen for thyroid lesions in patients who have been exposed to 
radiation. 
• To objectively monitor nodules, goiters or lymph nodes in patients 
undergoing treatment or observation of thyroid disease. 
• To monitor treated patients with thyroid cancer for early evidence of 
recurrence in the thyroid bed and cervical lymph nodes. 
• To facilitate therapeutic procedures such as sclerotherapy or laser 
ablation of thyroid nodules. 
• To detect undescended thyroid or thyroid agenesis. 
• To assess the size and location of the neonatal thyroid. 
• To refine management of patients on therapy such as antithyroid 
medications. 
Advantages of Ultrasound 
1. Versatile 
2. Speed of diagnosis 
3. Easily available 
4. No risk of ionizing radiation 
5. Portable 
6. Low cost 





1. Gives only a clue to the diagnosis, does not offer pathological diagnosis. 
2. It is operator dependent. 
Side effects 
 Thermal heating of tissues and cavitation effects are seldom a problem 
with the frequencies and output energy used in diagnostic medicine. 
SONOGRAPHIC ANATOMY OF THE HEAD AND NECK 
 A thorough knowledge of the anatomy of the head and neck is essential 
to understanding the ultrasonographic appearance of this region. This makes 
the surgeon better suited for performing the ultrasound. 
 An ultrasound examination should follow a systematic and thorough 
course to ensure that all the structures of the neck from clavicle to mandible are 
evaluated. The examination is performed in both the axial and longitudinal 
planes. 
 The sonographic appearance of fat is hyperechoic relative to muscle, 
which is hypoechoic. Cervical fascia is very echogenic and appears as a 
whiteline that demarcates the structures from one another. Mucosa is also 
echogenic. Arteries are anechoic and pulsations can often be seen. Veins are 
also anechoic and are compressible by pressure with the probe. 
 Normal thyroid parenchyma is hyperechoic and homogenous compared 
with the relatively hypoechoic strap muscles, that border the gland anteriorly. 
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Interruption of the fascia surrounding the gland should alert the sonologist to 
the possibility of extra thyroidal extension by a malignancy. There is an 
anechoic space between the thyroid and capsule, representing the capsular 
vessels. 
 There is a slight asymmetry between right and left thyroid lobes. The 
pyramidal lobe is not commonly seen because of its small diameter. The 
trachea lies posterior to the thyroid and the common carotid arteries border the 
gland laterally on each side. The thyroid is bounded by the sternocleidomastoid 
anterolaterally and by the oesophagus and longus colli muscles posteriorly. 
 The size of the thyroid is influenced by factors such as alcoholic 
cirrhosis, renal failure, smoking, parity, iodine intake, TSH, use of OCP, 
gender, age, BMI. Lean body mass and body surface area are the major 
determinants of thyroid size.27 
Normal thyroid measurements 
 Longitudinal dimension  - 40 to 60 mm 
 Anteroposterior diameter - 13 to 18 mm 
 Thickness of the isthmus - 4 to 6 mm 
 The gland is enlarged if the AP diameter is more than 2 cm and the 
isthmus is thicker than 10 mm. Thyroid volume is calculated on an ellipsoidal 
model6. The height, width and depth are multiplied by a correction factor of 
0.529 or pi/6 and the volume of both lobes is added. The average volume is 
between 12 to 40 cm2.  
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In South Indian population the volume of normal thyroid is much less, 
each lobe is about 5 ml in volume in euthyroid individuals though WHO 
recommends a normal volume of 18 ml for women and 25 ml for men.49 
The oesophagus is seen on the posterolateral aspect on the left side. The 
air column and saliva in it appears echogenic with the surrounding muscle 
being hypoechoic, appearing like a target or bull’s eye. The patient can be 
made to swallow to visualize the oesophagus which relaxes. 
The normal parathyroid is seldom seen. Parathyroid adenomas appear as 
discrete oval nodules that are homogenously hypoechoic relative to the thyroid 
gland and the echogenic thyroid capsule may be visible separating these 
structures. Parathyroid glands are relatively incompressible compared with the 
adjacent soft tissue. Thus gentle compression over a suspected parathyroid can 
increase the conspicuity of subtle lesions A polar feeding vessel can be picked 
up by Doppler. 
 Concurrent thyroid disease can result in several imaging pitfalls. 
Acoustic penetration may be limited in the setting of large multinodular glands, 
obscuring the parathyroid tissue, posteriorly positioned thyroid nodules can be 
confused with the parathyroid especially when it is totally within the thyroid 
capsule. 
Imaging of cervical lymph nodes13 
 Until the early 1990’s cervical lymph node classification was based on 
anatomic location with the anterior nodal groups labeled as submental, 
15 
 
submandibular, internal jugular, supraclavicular, posterior triangle and parotid. 
This classification was cumbersome and a better topographic classification was 
adapted to aid in mapping nodal surgical intervention. The sonographic 
landmarks (proposed by the American Joint Committee on cancer and the 
American Academy of Otolaryngology) used in dividing the neck are slightly 
different from the anatomical landmarks. 
 The lateral compartment neck nodes (levels II through IV) are found 
around the jugulocarotid vascular bundle and may be under the 
sternocleidomastoid muscle. Level II-lymph nodes are located above the level 
of the hyoid bone to the base of the skull. Level III-nodes are between the 
levels of the hyoid bone and the cricoid cartilage. Level IV-nodes are below the 
level of the cricoid cartilage extending to the clavicle. Level V – transverse 
cervical chain and posterior triangle lymph nodes. The central compartment or 
anterior neck lymph nodes level VI are located posterior and inferior to the 
thyroid gland adjacent to the trachea and oesophagus. The compartment is 
bordered laterally by the medial carotid sheaths, extends superiorly to the hyoid 
bone and inferiorly to the sternal notch. Level VII are the superior mediastinal 
nodes. 
 The landmarks mentioned can be either imaged sonographically or 
palpated. 
Ultrasound imaging of normal lymph node 
 Normal lymph node morphology is characterized by a connective tissue 
capsule surrounding an outer cortex with the densely packed lymphocytes 
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forming lymphoid follicles and an inner medulla containing the blood vessels, 
lymphatic sinuses and connective tissue. 
 About 70% of normal subjects can harbor one or more normal lymph 
nodes. Therefore it is essential to appreciate the different imaging 
characteristics of benign and malignant lymph nodes. The evaluated parameters 
should include size, shape, presence of an echogenic hilus and a hypoechoic 
cortex, vascularity, cystic change, calcifications. 
 The size of the node may vary according to the region of the neck.  
A level II reactive node may appear larger due to hyperplasia from repeated 
oral infections. The long axis measurement may go upto 18mm in this region. 
The short axis diameter in this region varies less and does not exceed 8 mm. In 
other areas, it is 5 mm. 
 A normal lymph node is oval in shape and a short to long axis ratio is 
less than 0.5 mm. However normal nodes in the submandibular and parotid 
region may be round and the nodes in the central compartment may be round in 
reaction to chronic autoimmune thyroiditis. 
 A normal node exhibits a hypoechoic cortex with an echogenic central 
hilus. This hilus is often visualized in nodes larger than 5 mm. The 
echogenicity is due to hilar fat, which becomes prominent with age and the 
presence of intranodal arteries, veins and lymphatic sinuses. Hilar vascularity 
may be detected in 90% of normal lymph nodes with a transverse diameter 
greater than 5mm. Smaller nodes appear avascular. 
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Sonographic features in thyroid disorders 
 The superficial location of the thyroid and dramatic improvements in the 
resolution, have made ultrasound the modality of choice in diagnosing thyroid 
disorders. It is important for the surgeon to understand the spectrum of 
sonologic appearances of the common thyroid disorders. 
Goitre due to endemicity 52 
 The gland is uniformly enlarged and it may appear hypoechoic due to 
lack of iodine. There are no special features to call it endemic goiter. 
Colloid goiter 
 Initially, the gland is diffusely involved, and there is uniform 
enlargement. Accumulation of colloid within the follicular cells, can be seen as 
small cystic spaces giving the gland a honeycomb or spongiform pattern. The 
small cystic spaces, which are anechoic coalesce to form larger cystic spaces 
and cystic nodule. Rarely are the cysts simple, virtually all cystic nodules have 
a solid component which has to be distinguished from a cystic, necrotic 
malignancy. 
 When ultrasonography of a fluid filled cyst is done, the posterior wall of 
the cyst and area distal to the cyst is bright or enhanced. Some solid nodules are 
so hypoechoic, that they mimic a cyst, but careful examination slows that the 
posterior enhancement is lacking. 
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 A prominently cystic lesion is more likely to be benign, as most of the 
cystic papillary carcinomas have a cystic component that rarely exceeds 50%. 
 Degeneration and Haemorrhage in a colloid nodule leads to dystrophic 
calcification, these calcifications are quite dense, reflect sound waves causing 
bright images on the ultrasound screen. They are large coarse,  the area distal to 
the calcification appears dark due to blockage of sound waves causing acoustic 
shadowing. 
 Occasionally a bright spot can be seen in a nodule that resembles a 
calcification, but instead of shadowing, a blurred brightness is seen distally, the 
so called ‘comet tail’ or ‘ring down’ effect, also referred to as a ‘cat’s eye’ – a 
sign of colloid crystal in a benign colloid nodule. 
 Sometimes, the cyst can be complex with septations. 
Hashimoto’s thyroiditis 
 It is the most common form of thyroiditis with a 9:1 female/male ratio. 
Patients typically present with a painless lobular, diffusely enlarged thyroid 
gland often with hypothyroidism. Because not all patients have antithyroid 
antibodies and many are euthyroid at the time of diagnosis, ultrasound is a 
useful adjunct, when the disease is unsuspected clinically. 
 Lymphocytic infiltration of the gland with follicle destruction leads to 
hypoechogenicity and the degree of hypoechogenicity correlates with the 
likelihood and severity of hypothyroidism.32 
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 In the initial stages the gland is heterogenous and has a coarse echo 
texture compared with normal thyroid. There is either normal or increased 
vascularity when imaged with colour Doppler and the increased vascularity is 
associated with the development of hypothyroidism caused by trophic 
stimulation of the gland by TSH24. Later, there may be decreased vascularity. 
 The presence of hypoechoic micronodules ranging in size from 1 to 7 
mm surrounded by an echogenic rim of fibrosis is specific for the disease with 
a 95% PPV. As the disease progresses, the gland developes echogenic linear 
bands of fibrosis which become confluent and thicker. Occasionally 
Hashimoto’s thyroiditis may present as a focal nodule1 or nodules with 
diffusely altered parenchyma or in a sonographically normal gland. The most 
common form of a thyroid nodule is a homogenously hyperechoic solid nodule, 
the so called ‘white knight’5 likely representing a regenerating nodule. 
Sometimes bright blocks separated by dark bands resembling giraffe’s hide as 
described by Bonavita can also be present. Ocassionally ill defined margins, 
cystic changes and intranodular calcifications are also observed.30 
 Several enlarged and atypical appearing central compartment lymph 
nodes can be found adjacent to the lower poles of both lobes.50 Although 
reactive lymph nodes are seen in Hashimoto’s thyroiditis, the presence of 
microcalcifications, cystic change, peripheral vascularisation, echogenic lymph 






 The disease is caused by binding of stimulatory thyroid auto antibodies 
to the TSH receptor on the follicular cells, resulting in increased hormone 
synthesis and secretion and growth of the thyroid gland. Diffuse hypertrophy 
and hyperplasia of follicular cells with colloid depletion and lymphoid 
infiltration are seen at histology. 
 There are no specific grayscale ultrasound findings. There is diffuse 
enlargement, convex bowing of the anterior gland margin and mild textural 
coarsening. The echogenicity may be normal, but may be decreased to variable 
degrees because of increased intrathyroidal blood flow, functional changes in 
thyroid follicles with increased cellularity and decreased colloid content. This 
may be similar to Hashimoto’s disease but is less heterogenous and the contour 
is less lobular. Focal nodules and malignancy can also be picked up in Graves 
disease. 
 Early colour Doppler studies, suggesting the ‘thyroid inferno’ pattern43 
due to increased vascularity may be highly specific for the disease. Normal 
thyroid parenchyma shows occasional spots of flow on colour Doppler; peak 
systolic velocities between 15 and 30 cm/s in the intrathyroidal arteries. In 
untreated active Graves disease, the thyroid blood flow is 15 fold higher.4 
 Saleh and colleagues have demonstrated a threshold peak thyroid artery 
systolic velocity of more than 60 cm/s, had a 100% specificity and 80% 
sensitivity for distinguishing Graves from other causes of diffuse toxic goiter. 
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A cut off of 4% greater systolic flow could be used to discriminate Graves from 
destruction induced thyrotoxicosis. 
 Colour Doppler may also be used to determine the response to 
treatment7. A significant decrease in flow velocities in the superior and inferior 
thyroid arteries after treatment has been reported. Low thyroid echogenicity 
and high flow in the thyroid artery and parenchyma may be specific for 
prediction of relapse of hyperthyroidism. Radioiodine therapy results in 
scarring and atrophy of the thyroid gland. 
Simple multinodular goiter 
 Several complex interactions between environmental, genetic and 
endogenous factors causes diffuse simple goiter. Haemorrhagic necrosis and 
scarring of connective tissue limits the polyclonal growth of follicular cells 
resulting in nodularity. 
 This results in replacement of thyroid parenchyma by isoechoic nodules 
with haemorrhage, necrosis and colloid accumulation causing variable cystic 
changes. Dystrophic calcifications result in coarse calcifications being seen. 
 The risk of malignancy in each individual nodule within a multinodular 
gland decreases by a rate proportional to the number of nodules.14 The 
American Thyroid Association recommends analyzing the sonographic features 






 Adenomas comprise 5% to 10% of thyroid nodules. They are often 
functional, but rarely hyperfunctional. True adenomas have a capsule as 
opposed to hyperplastic nodules which do not. They can be hypoechoic, iso or 
hyperechoic. Rarely they can also demonstrate cystic degeneration and coarse 
calcifications. Doppler vascular analysis visualizes central branches of vessels 
coming from the capsule into the center of the adenoma, so called ‘spoke and 
wheel’ arrangement. 
Ultrasound characteristics of malignant lesions 
 Most of the nodules are benign. Only about 10% are malignant. 
 Risk factors for malignancy include male gender, advanced age, 
exposure to ionizing radiation, family history of thyroid cancer. 
The features of a nodule which suggest malignancy26 
1. Margins   Blurred, ill defined 
2. Halo rim   Absent 
3. Shape    Irregular, spherical tall 
4. Echo structure  Solid 
5. Echogenicity   Hypoechoic 
6. Calcifications  Microcalcifications 
7. Vascular pattern  Intranodular, hypervascular 




 Does not predict malignancy significantly. The risk of malignancy is 
about 10% and is the same in both nodule size more than or less than 1 cm37. 
Risk of sub centimeter nodules increases when there is a family history of 
malignancy, exposure to ionizing radiation, history of thyroid cancer or nodules 
avid for FDG on PET scan. 
Margins and halo 
 Benign lesions have a circumferential halo which represents compressed 
thyroid tissue and a capsule. Malignant lesions may not possess a halo or it is 
partially present. A blurred or a ill defined margin increases the risk of 
malignancy.28 
Nodule Shape 
 Spherical, irregular and nodules that are more tall than wide26 are likely 
to harbor cancer. 
Echo structure 
 Malignant nodules are more likely to be solid or have mixed 
echogenicity.28 
Echogenicity 
 The echogenicity of the thyroid nodule should be compared with that of 
surrounding thyroid tissue. Benign nodules are slightly hypoechoic while 




 Eggshell calcifications result from previous haemorrhage and 
degenerative change and are considered a benign feature. 45% - 60% of 
malignant nodules may show microcalcifications26 which are less than 2mm 
and do not cause posterior acoustic shadowing. Coarse calcifications are more 
likely to be benign, while some of the long standing malignancies also show 
coarse calcifications. 
Vascular pattern 
 Chammas8 and colleagues classified thyroid nodules according to the 
pattern of vascularity seen with power Doppler into five types : absent blood 
flow, perinodular flow only, perinodular flow greater than central blood flow, 
mainly central nodular flow, central flow only. Nodules with exclusively 
central blood flow or central flow greater than perinodular flow had a higher 
incidence of malignancy. 
Elastography 
 It is the ultrasound measurement of tissue elasticity, a mechanical 
property reflecting the deformation or distortion of the tissue in response to the 
application of external compression. The displacement of the strained tissue is 
estimated by tracking the echo delays in segmented waveforms recorded before 
and after quasistatic compression. The sensitivity and specificity varies 





 It is the most common thyroid malignancy representing 70 to 80% of the 
thyroid cancers. Ultrasound features include solid, hypoechoic lesion with 
microcalcifications, cystic components may be present within a solid lesion, ill 
defined margins are common. Doppler reveals disorganized hypervascularity. 
Microcalcifications may be the most specific for PTC because psammoma 
bodies, composed of tiny laminated spherical collections of calcium that reflect 
sound waves appear as tiny bright foci. 
Follicular carcinoma 
 It accounts for 10% of thyroid malignancies. Unlike PTC it is more 
likely to spread via hematogenous routes, accounting for higher incidence of 
distant metastasis and poor prognosis. 
 The lesion is typically, solid, hypoechoic and homogenous. Cystic 
change and calcifications are rare and more often seen in benign lesions. 
Hypervascularity is seen on Doppler examination. A halo is often seen, but it is 
not complete and the thickness is more than 4 mm. 
Hurthle cell carcinoma 
 They account for about 3% of thyroid cancers and 20% of these tumours 
are malignant. They are more aggressive than PTC. On ultrasound, Hurthle cell 
tumours are solid, both hypoechoic and hyperechoic with an irregular border. 




 Account for 5% of thyroid cancers. They arise from parafollicular ‘C’ 
cells and are concentrated in the superior poles. The lesion is solid and 
hypoechoic, and has hyperechoic foci, representing amyloid deposition, and 
calcification. These foci may appear within affected lymph nodes. 
Anaplastic carcinoma 
 It is the most aggressive type of thyroid cancer. Ultrasound shows a 
diffusely hypoechoic lesion, often infiltrating the entire thyroid lobe with areas 
of necrosis or ill-defined calcifications. Invasion into surrounding vessels or 
soft tissue is often seen. 
Lymphoma 
 Accounts for less than 5% of thyroid malignancies. Non Hodgkin 
lymphoma is the most common type and is associated with a history of 
Hashimoto’s thyroiditis. The clinical symptom of pain is often lacking. Local 
soft-tissue and vascular invasion are common. It may appear as a focal lesion 
or a diffuse abnormality involving the entire gland. The involved tissue is 
usually heterogenous and hypoechoic and may be mistaken for anaplastic 
carcinoma. Pseudocysts with posterior enhancement are sometimes seen. 
Metastalic disease 
 Lymphoma, melanoma, renal cell carcinoma, lung, colorectal cancer and 
breast cancer metastases have been described. Although they have a variable 
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sonographic picture, most of them are hypoechoic with well defined margins 
and lack of halo and calcifications. They are usually multinodular, occasionally 
can occur as solitary nodule or a heterogenous pattern when the thyroid is 
diffusely involved. 
Table 1 : FNAC AND HPE Features of thyroid disorders 
Non – neoplastic disorders of the thyroid 
 
Gross findings Histology Cytology 
Ultrasound 
Features 
i. Adenomatoid nodule 
: 
Enlarged gland with 
multiple nodules of 
variable size  
Cut section gelatinous 
Degenerative changes 
seen 
Capsule absent or 
pseudo capsule 
Large follicles 
distended with colloid  
Epithelial cells 
flattened Oxyphilic 
cells may be present 
Cellular nodules with  
increased cellularity 
and little colloid 
papillary fronds seen. 
low cellularity and 
abundant colloid 
Follicular 
epithelium in honey 
comb pattern  
Haemosiderin laden 
macrophages may 
be seen Coexistence 
of involutional and 
hyperplastic 
follicular cells  
Iso, hyper or 
hypoechoic 
nodules with or 
without 
degeneration, 





ii. Acute thyroiditis: 
Erythematous gland soft 
with pockets of purulent 
exudate or necrosis 
Neutrophilic 
infiltration,  




Neutrophils seen Hypoechoic gland 
complex fluid 
containing bright-









wholegland nodular  
(i) Early stage: 
Follicles disrupted by 
lymphohistiocytic 
infiltrate with 
neutrophils in lumen  
(ii) Late stage : 
multinucleated giant 
cells more prominent 
Extensive destruction 
of follicular epithelium 
obscuring follicle 
centred disease. 
iii. Resolution : Follicle 
Lymphocytes, 
histiocytes,  plasma 
cells multinucleated 
giant cells seen 
Colloid and 
follicular cells scant 
Hypoechoic areas 
along the long 
axis of the gland 
corresponding to 









iv. Reidel’s Thyroiditis 
: Pale woody thyroid 
with ragged borders 
diffuse enlargement and 
adherent to strap 
muscles & soft tissues 
Extension into soft 





monocytes, neutrophils  
Rare follicles occlusive 
phlebitis with thickened 




scant material with 










Gland  grossly enlarged, 
pale grey to white, 
consistency like 
lymphoid tissue, distinct 
modules in long standing 
cases 
Diffuse infiltrate with 
lymphocytes, plasma 
cells histiocytes, rarely 
giant cells.  
Follicular atrophy with 
oxyphilic metaplasia, 
lympho epithelial cysts  
Mixed polymorphic 





Giant cells and 
histiocytes. 
Oxyphilic epithelial 
cells – Askanazy 
cells, Scant colloid 
Hypoechoic gland 
with swiss cheese, 
giraffe hide, bag 
of marbles 
appearance. Late 





vi. Graves disease:  
Beefy red, diffuse 
enlargement Treated 
cases may appear 
nodular  
 





cells columnar.  
 
Follicular nuclei round, 
enlarged and basally 
oriented.  
Scalloping if colloid 
present. 





Highly cellular  
minimal or no 









bowing of the 
anterior margin. 










nodular, Nodules opaque  
Hypercellular with 
microfollicular or solid 
pattern, little colloid. 
Fibrosis prominent, 
cytologic atypia in 
parenchyma between 
nodules  
Highly cellular with 
small sheets and 
clusters of follicular 






II. Benign neoplasms    
(i) Follicular adenoma: 




Intact capsule, No 
invasion Smooth 
muscle walled vessels 
present in fibrous 
connective tissue, 
colloid present. 
Variants – Trabecular, 
oncocytic, fetal, 



















   
i. Papillary carcinoma: 
Grey white firm mass 
with irregular borders 
often circumscribed. 
calcifications with gritty 
surface. 
Extrathyroidal capsular 
extension can be seen 
Variable growth 
pattern, complex 






sclerosis, crystals, giant 















nuclear grooves and 
intranuclear 
inclusions Ropy 
bubble gum colloid 
Hypo or hetero 
echoic nodules 
with irregular 









Capsular or vascular 
invasion 
Cellular with follicular, 
solid and trabecular 
growth. Enlarged cells 
with round to oval 
nuclei Oncocytic cells 
have large centrally 
placed macronucleoli 





cells forming small 
ring like structures 














Encapsulated with tan 




Entrapment of benign 
follicular epithelial 
cells. Round to oval 
spindle to plasmacytoid 
cells. round to oval 
nucliei with stippled 





Single cells & 
loosely cohesive  
clusters. Colloid 
absent Amyloid 










iv. Primary thyroid 
lymphoma 
Soft to firm, 
multinodular cut surface 
bulging, tan and fish – 
flesh, Homogenous 
mottled extension into 




cells Dutcher bodies 
and Russell bodies 
lymphoepithelial cells 
are diagnostic  






monocytoid B cells, 
immunoblasts. large 

















VARIANTS OF PAPILLARY CARCINOMA 
Follicular variant 
 Encapsulated, small tight follicles with scant, hypereosinophilic colloid, 
papillae absent or rare, classic nuclear features of papillary carcinoma are seen. 
Macrofollicular variant 
 Resembles adenomatoid nodules or hyperplastic nodules, 
large/macrofollicles with increased cellularity accentuated at the periphery 
colloid is scalloped or vacuolated. Abortive, rigid, straight papillary structures 
extend into the center of the follicle lined by atypical cells. 
Oncocytic variant 
 > 70% papillary architecture. Enlarged cells with abundant oncocytic 
cytoplasm, apically oriented enlarged nuclei, increased intranuclear, 
cytoplasmic inclusions. 
Clear cell variant 
 Clear cytoplasm, oncocytic and clear cells combined. 
Diffuse sclerosing variant 
 Diffuse, bilateral involvement, extensive fibrosis, innumerable 
psammoma bodies, extensive intravascular growth and extrathyroidal 
extension, florid squamous metaplasia, dense lymphocytic thyroiditis, solid or 
papillary growth of papillary carcinoma cells. 
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Tall cell variant 
 > 70% of tumour composed of cells 3 times tall, oncocytic cytoplasm 
increased intranuclear cytoplasmic inclusions, centrally placed nuclei within 
cell. 
Columnar cell variant 
 Prominent papillary growth, parallel follicles (railroad tracks) scant 
colloid, syncytial architecture with prominent nuclear stratification. Coarse 
nuclear chromatin, subnuclear cytoplasmic vacuolization, squamous metaplasia 
as morules and increased mitotic figures. 
Solid / Insular variant 
 Solid or insular pattern with nuclear features of papillary carcinoma. 
Micro carcinoma 
 Incidentally found < 1 cm, papillary carcinoma with a proclivity for 
thyroid subcapsular location. 
Ultrasound imaging of metastatic lymph nodes 
 Size of the lymph node plays little role in the evaluation of malignancy. 
Since neoplastic infiltration of a lymph node begins in the cortex, malignant 
nodes have a larger transverse diameter and a rounder shape with an S : L of 
0.5 or higher. A round shape is suggestive of malignancy, but its specificity 
may depend on the region of the neck. Peripheral neoplastic infiltration results 
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in loss of the hypoechoic cortex and may be replaced by a hyperechoic 
appearance. The node later becomes heterogenous and there may be intranodal 
calcifications cystic necrosis is also common and the echogenic hilus is lost. 
 Jugular compression or displacement of the jugular vein from the carotid 
artery suggests malignancy. 
 Colour or power Doppler examination shows that the vascular pattern is 
either peripheral or diffuse (hilar and peripheral) often with irregular 
distribution.  The increase in peripheral nodal vascularity occurs because of 
initial deposition of the malignant cells in the marginal sinuses and the tumour 
induced angiogenesis causes subsequent neovascularisation. As infiltration 
proceeds, increased vascularity is apparent throughout the lymph node. 
 In medullary carcinoma, the nodes are hypoechoic, rounded with a 
central coarse calcification. In lymphoma the nodes have a characteristic fish 
flesh appearance with uniform hypoechogenicity and loss of fatty hilum. 
Imaging surveillance of Thyroid cancer22 
 After the initial treatment, patients must be monitored regularly for 
recurrent disease utilizing clinical examination thyroglobulin measurement and 
sonological imaging. 
 The normal post thyroidectomy bed site appears as an inverted triangle 
of heterogenous echogenic tissue reflecting the proliferation of fibrofatty 
tissues within the operative bed. This triangle is bounded anteriorly by the 
overlying strap muscles, medially by the trachea and laterally by the carotid 
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and internal jugular vessels. Post operative edema, seromas and hematomas can 
distort the tissue planes in the immediate postoperative period. Before radio 
iodine ablation, the tissue in the thyroid bed appears as vascular lobules equal 
in echogenicity to the thyroid gland. Following ablation, the tissue appears as 
hypoechoic heterogenous nodules without internal vascularity. 
 Thyroidectomy bed recurrence typically appears as well defined 
hypoechoic oval nodules within the resection bed. A small proportion of 
recurrent nodules may contain microcalcifications. 
 As the sonographic features of recurrence are non-specific, a number of 
conditions may be mistaken for a recurrence. Suture bed granuloma may be 
present for years after surgery and one specific sonographic sign that can 
suggest this diagnosis is that presence of central linear echogenic lines within a 
hypoechoic nodule double parallel lines greater than 1 mm in width are 
particularly characteristic. 
 Other features which can be mistaken for recurrence are remnant 
thyroid, fibrosis, suture granuloma, strap muscles, reactive lymph nodes and fat 
necrosis. 
 Gray-scale sonographic features of metastasis include 
microcalcifications, cystic change, round shape, hyperechogenicity absence of 




REVIEW OF LITERATURE 
 The ultrasound features of thyroid nodules that should be analysed are 
summarized in the consensus statement on thyroid nodules from the Society of 
Radiologists in Ultrasound (SRU)14 and The American Association of Clinical 
Endocrinologists (AACE)16. 
Table 2 : Sonographic features of malignancy and benignancy in the 
thyroid nodule (from Solbiati et al54.) 
 
Feature Benign Malignant 
Internal contents 
 Purely cystic contents 
 Cystic with thin septa 
 Mixed solid and cystic 
























 Thin regular halo 








 Well defined 








 Eggshell calcifications 











 Peripheral flow pattern 








+, rare probability (<1%); ++, low probability (<15%); +++, intermediate 




Tae et al classified thyroid nodules into three categories based on their 
having one or more of four features: nodules with microcalcifications, irregular 
or microlobulated margin, marked hypoechogeneicity and a shape that is taller 
than it is wide is classified as malignant. Nodules with the absence of all these 
are benign. Anechogenic cystic nodules are category 1. The sensitivity and 
specificity, PPV and NPV were 87%, 87%, 48% and 98% respectively. 
66% of papillary thyroid cancers have at least one sonographic feature 
that is not typically associated with malignancy and 69% of benign nodules 
have one sonographic predictor of malignancy. Table 2 shows the significant 
overlap between the various features in benign and malignant lesion.54 
Echogenicity may appear to be a robust observation, the interobserver 
reproducibility is only moderate62 20-30% of papillary carcinomas can be 
cystic. Halos may be found in 30% of papillary carcinomas but they are 
incomplete and, in about 87% of follicular carcinomas. 20-30% of papillary 
carcinomas can be cystic. Microcalcifications can be present in 7-14% of 
benign lesions.23 Coarse calcifications can be seen in both benign and 
malignant lesions and are associated with malignancy when they appear with 
microcalcifications or in the center of a hypoechoic nodule. Egg shell 
calcifications are usually present in benign lesions, but rarely can be associated 
with malignant lesions. Table 3 compares the sensitivity, specificity positive  
predictive values and negative predictive values of each of these sonographic 
criteria from 6 large studies. 
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Clinical Hypoecho-genicity (%) Shape Spherical/ 
Tailer Than Wide (%) Spiculated Margins (%) Microcalcifications (%) 
   Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV 
Takashima 
et al 259 
P & 
NonP 83 49 40 89 - - - - 72 63 44 85 36 93 70 78 
Kim et al 155 NonP 26.5 94.3 68.4 73.5 32.7 92.5 66.7 74.8 55.1 83 60 85 36 83 60 80 
Papini et al 402 NonP 87.1 43.4 11.4 - - - - - 77.5 85 30 80 55.1    
Nam-
Goong et al 
317 NonP 68.2 52.9 27 - - - - - - - - - 36.4 85.5 39 - 
Capelli et 
al 
701 NonP 79.1 53.3 15.1 96 83.6 81.5 32.4 97.9 47.8 74.3 16.4 93 73.1 69.2 20 96 
Moon et al 849 P & 
NonP 
87.2 58.5 60.7 86.1 40 91.4 77.4 67.4 48.3 91.8 81.3 70.7 44.2 90.8 77.9 68.8 
 
Abbreviations : NonP, nonpalpable; NPV, negative predictive value; P. Palpable; PPV, positive predictive value 
a Marked hypoechogenicity 
b Clustered blurred and speculated margins together 
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As shown in Table, individual sonographic signs are only moderately 
sensitive and specific for predicting malignancy in solid thyroid nodules, there 
can be a significant overlap with benign processes, because almost 70% of 
histologically proved benign nodules may exhibit 1 suspicious sonographic 
sign.62 However malignant nodules tend to harbor multiple suspicious findings, 
a mean of 2.6 abnormalities.26 The only single  sonographic feature that is 
considered to be safely benign is a purely cystic nodule. However combining 
features into a pattern may be helpful when triaging nodules. There are five 
patterns that have been shown to have high specificity for benignity.5 
Likely benign patterns 
1. Cystic nodules with or without internal Echogenic foci 
 Nodules that are small, less than 10 mm, fluid filled and solitary or 
multiple are benign. These are colloid filled cysts and exhibit a echogenic focus 
with a posterior reverberation known as comet tail or ring down artifact. 
Bonavita and colleagues have read these nodules pathologically as benign 
colloid nodules.5 
2. Honey comb or spongiform pattern 
 This has innumerable tiny cystic spaces separated by thin bands or 
septations. It is usually avascular and occasionally vascularity can be identified. 
Echogenic foci if present are linear and are associated with the back wall of the 
tiny cysts, and thus are distinguished from microcalcifications in malignant 
nodules. Ginat17 has shown that honey comb morphology has 100% specificity 
for benign nodular hyperplasia. 
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3. Large predominantly cystic nodules 
 The large amount of fluid may be secondary to degeneration, colloid or 
sequelae of haemorhage and only benign nodules demonstrate so much of 
cystic change. It is rare to find a malignant lesion which is more than 50% 
cystic.19 But this can be applied only to nodules in the thyroid and nodal 
metastasis are often cystic. 
4. Innumerable tiny nodules 
 Multiple tiny hypoechoic nodules separated by coarse echogenic bands 
has a 95% positive predictive value for Hashimoto’s thyroiditis.65 About 16% 
of nodules larger than the background nodularity are malignant and so discrete 
larger nodules should be evaluated for malignancy. 
5. Markedly hyperechoic 
 It is 100% specific for a benign nodule5. This is a colloid type nodule or 
focal nodular Hashimoto’s thyroiditis. 
Worrisome Pattern 
1. Solid hypoechoic nodules with discrete echogenic foci 
 This has a high probability for papillary thyroid carcinoma. However 
hypoechogenicity by itself may be seen in several benign nodules, but 




2. Solid hypoechoic nodules with coarse echogenic foci 
 This may be either a papillary or medullary carcinoma. Coarse 
calcifications may be due to aggregation of psammoma bodies or due to 
fibrosis of amyloid deposits seen in medullary carcinoma or due to dystrophic 
calcification in a benign nodule. However a combination of coarse central 
calcifications with hypoechogenicity is worrisome. 
3. Solid homogenous egg shaped nodules with a thin capsule 
 These lesions may be isoechoic, hyperechoic or hypoechoic. Both 
benign and malignant lesions have this appearance. Sillery et al53 found that 
hypoechogenicity, lack of cystic change or halo and a larger size favour 
malignant follicular carcinoma. 
4. Refractive shadow from the edge of a solid lesion 
 This occurs at the junction of two tissues with differing sound 
propagation velocities at an oblique angle to the sound wave and is due to 
dense fibrous tissue at the periphery of a papillary carcinoma.44 
 Based on a combination of nodule characteristics the American Thyroid 
Association (ATA)59 and the Society of Radiologists in Ultrasound (SRU) have 




Criteria for FNAC 
Size of Nodule 
(mm) 
ATA SRU 




10 – 15 FNAC if microcalcifications 
or is solid 
FNA if microcalcifications 
present 
15 – 20 Microcalcifications, is solid, 
or is both solid and cystic 
with suspicious features 
FNA if microcalcifications or 
is solid with coarse 
calcifications 
> 20 FNA of all solid nodules Substantial growth cystic 
with mural nodules 
 
 The FNAC results of such lesions were prospectively correlated with the 
defined ultrasound patterns and a TIRADS (The Thyroid Imaging Reporting 
and Data System) group classification was generated21. The following 
categories were established. 
TIRADS 1. Normal thyroid gland 
  2. Benign conditions (0% malignancy) 
  3. Probably benign nodules (5% malignancy) 
  4. Suspicious nodules (5-80% malignancy) 
  5. Probably malignant 
  6. Definitely malignant, proved by FNAC 
 The sensitivity, specificity, PPV, NPV and accuracy were 88, 49, 49, 88 
and 94% respectively for the TIRADS system. 
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Lymph node imaging 
 Ultrasound is a superior adjunct in the evaluation of cervical lymph node 
metastases. CT and MRI provide information regarding the size of the 
suspicious node, but size itself is an unreliable criterion for malignancy. 
 Identification of metastatic adenopathy is the principle goal of lymph 
node sonographic imaging. Preoperative assessment of cervical lymph nodes is 
important in staging and will often determine optimal treatment approaches to 
cancers in the head and neck. The presence of adenopathy in the head and neck 
can be the result of underlying inflammation in upto 50% of cases. Conversely 
20 to 40% of normal size nodes may harbor metastasis.11 
 Although large size is more commonly associated with malignancy, 
33% to 71% of nodal metastates were found to have a maximum transverse 
diameter less than 1 cm.60 
 A long/short axis ratio of greater than 2.0 is predictive of inflammatory 
disease in 84% whereas a ratio less than 1.5 indicates metastatic disease in 
71%55. This has a sensitivity of 81% to 95% and specificity of 67% to 96% in 
determining metastatic involvement of the lymph node. Furthermore the cut of 
L/S values for different cervical lymph node stations have been calculated. 
Submental-2 submandibular-1.4, parotid-2.0, upper cervical-2.5, middle 
cervical-3.3 and posterior triangle-2.5.66 
 Echogenicity of the node is a weak parameter in predicting malignancy 
11% of reactive nodes can be heterogenous, 38% of metastatic nodes can be 
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homogenous35. If the cortex is less than one half of the transverse diameter, the 
probability of malignancy is < 9% whereas eccentric cortical thickening is 
suggestive of nodal metastasis.61 
 Nodal margin may not be a indicator of the pathology, as Moritz et al41 
noted that 46% of metastases had well defined margins and 14% of 
inflammatory nodes had ill-defined margins. The value of Doppler in this 
regard remains to be evaluated. 
 Multivariate analysis suggests that the criteria most predictive of 
metastatic cervical lymph node are absent hilar echoes and increase in short 
axis length. 
 Cervical ultrasound is the mainstay of DTC surveillance imaging and 
has replaced I131 WBS as the primary imaging modality. WBS has a sensitivity 
of 20% for the detection of local recurrence versus 70% for cervical 
ultrasound.69 
FNAC of thyroid 
 It is a minimally invasive relatively painless, cheap and speedy 
diagnostic modality, established as the first line diagnostic test by a large body 
of world literature. 





Table 4 :  Diagnostic yield of thyroid fine-needle aspiration 
 











Hawkins, et al. 1,399 2.4 4.6 86 95 
Khafagi, et al. 618 4.1 7.7 87 72 
Hall, et al. 795 1.3 3.0 84 90 
Altavilla, et al. 2,433 6.0 0.0 71 100 
Gharib, et al. 10,971 2.0 0.7 98 99 
Ravertto, et al. 2,014 11.2 0.7 89 99 
 
 These studies implicate that though FNAC has good sensitivity and 
specificity, it still has a false negative rate and so cases managed conservatively 
based on benign cytology have to be followed up closely. 




(n = 1097) 
TIRADS 2 
(n = 62) 
TIRADS 3 
(n = 326) 
TIRADS 4 
(n = 642) 
TIRADS 5 
(n = 67) 
Benign 62% 280 (85.9%) 353 (55%) 7 (10.4%) 
Follicular lesion 0% 35 (10.7%) 199 (31%) 2 (3.1%) 
Cancer 0% 11 (3.4%) 90 (14%) 58 (86.5%) 
 
 
 This shows that ultrasound can be used to triage nodules and subject the 




Aim of the Study 
 To evaluate the relevance of ultrasound in the diagnosis and surveillance 
of malignancy of the thyroid. 
Objective 
 To identify a group of patients in whom the nodule is malignant and 
would benefit from early aggressive treatment while avoiding unnecessary 
investigation and surgery of patients with a benign nodule. 
Period of Study 
 March 2010 – January 2012. 
Place of Study 
 Department of Endocrine Surgery, Department of Radiology and 
Pathology, Madras Medical College and Rajiv Gandhi, Govt. General Hospital, 
Chennai. 
Study Design 
 Prospective, cohort study. 
Study Material 
 All patients with goiter attending the OPD of Endocrine Surgery 





 Patients with goiter attending the OP Department of Endocrine Surgery 
who give informed consent for the study. 
Exclusion Criteria 
 Patients who did not undergo surgery / who were not willing for surgery 
were excluded from the study. 
No. of Cases 
 350 cases who underwent total thyroidectomy were taken for anlaysis. 
Method of Study 
 These patients were evaluated clinically and a baseline thyroid function 
tests was obtained. Ultrasound of the neck was performed by radiology 
residents on a rotation using Siemens Acuson Antares Premium model with a 
7.5 to 15 MHz linear array transducer probe in the Department of Radiology. In 
euthyroid patients FNAC of the thyroid was performed by pathology residents 
in the Department of Cytology, using the non-aspiration technique with a  
23 mm gauge needle. Slides were fixed in isopropyl alcohol and H&E staining 
was done. Slides were reported based on the Bethesda system of 
cytopathology. 




 Ultrasound of the neck was performed by a single surgical resident at 
the time of admission, blinded for the sonographic and FNAC report, using a 
DUS 3 Digital Ultrasonic Diagnostic Imaging System with a multifrequency 5-
15 MHz linear array transducer probe. 
 Thyroid ultrasound was performed with the patient in a supine position 
and with a pillow placed between the shoulders to allow hyperextension of the 
neck. Images were obtained in the transverse and longitudinal planes. The 
lobes of the thyroid and focal lesions were measured in three dimensions. 
Intrathoracic extension if thyroid disease were demonstrated by angling the 
ultrasound transducer into the mediastinum from a supra-manubrial position 
with additional maneuver such as swallowing.  For imaging large goiters with 
increased antero-posterior diameter, the frequency of the probe was reduced 
from 7.5 MHZ to 5 MHz. 
 The following parameters were noted during the time of sonographic 
examination. 
1. The echotexture of the lobes 
2. presence of nodularity 
3. the number of nodules (single, multiple)  
4. the echogenicity of the nodules 
5. the location of nodules (unilobar/bilobar) 
6. the presence of halo 
7. the regularity of the margins, presence of calcifications – micro, coarse 
and egg shell. 
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 Doppler was not performed and so Doppler findings were not included 
for analysis. 
For imaging the cervical lymph nodes, the transducer was placed on the 
mandibular gland in a horizontal orientation and moved inferiorly along the 
external carotid artery to the bifurcation of the common carotid artery. It was 
then centered over the jugulocarotid sheath and moved inferiorly till the carotid 
was visualized joining the subclavian artery on the right or disappeared under 
the clavicles to enter the arch on the left. The supraclavicular fossa and 
posterior triangle of the neck then examined by moving the probe laterally 
along the supraclavicular region and then posteriorly and superiorly to the 
mastoid region along the posterior edge of the sternocleidomastoid. 
For imaging the central neck, the transducer was placed in the transverse 
orientation above the tracheal cartilage at the approximate level of the hyoid 
bone and moved inferiorly along the anterior border of the trachea to the sternal 
notch. The more focused examination of the left and right paratracheal regions 
required centering the probe between the trachea and respective carotid artery 
just inferior to the tracheal cartilage and scanning inferiorly to the sternal 
notch. Longitudinal imaging was performed for identified abnormal lymph 
node. Hard copy of the data was saved for future reevaluation. 
Ultrasound classification for thyroid nodules 




Ultrasonographic features  Diagnosis 
Round or oval anechoic lesion - Cyst 
Regularly shaped nodule with cystic change 






Solid, hypoechoic, iso echoic or hyperechoic 
nodule with or without calcifications with a 
regular halo 
- Adenoma 
Hypoechoic / Heteroechoic gland with or 
without nodules with or without calcifications 
- 
 
Thyroiditis Hypoechoic gland with small nodules with 
echogenic bands across both the lobes of the 
gland 
Hypoechoic / Heteroechoic nodule with 
regular/irregular margins with fine/coarse 
calcifications 
- Pap Ca 
 
 For diagnosing nodal metastasis, Antonelli’s criteria excluding size of 
the node – hypoechoic with loss of fatty hilum, heteroechoic irregular cystic 
appearance, rounded or bulging shape presence of internal calcification was 
used. 
 Imaging surveillance of post thyroidectomy cancer patients was done 
after 6 months following surgery and radioablation and once in 6 months 
thereafter, along with Thyroglobulin and antithyroglobulin antibody levels as 
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per the revised ATA thyroid cancer guidelines. Suspicious nodes, thyroid bed 
recurrences if detected were subjected to FNAC and reoperative procedures 
adopted if indicated. 
 The post surgical specimen was grossed, fixed in formalin. Paraffin 
embedded tissue was sliced to 2 cell thickness and stained with Haematoxylin 
and Eosin. Reporting was done as per the Department protocol. The slides were 
reviewed by a single pathologist and the final opinion was taken for analysis. 
Statistical analysis 
 Data was analysed using a 17.0 SPSS software. The results of the SPUS  
was compared with that of the RPUS, FNAC and HPE by cross tabulation. 
Ranking of the variables was done using the Mann - Whitney non-parametric 
test and correlated by Kruskal Wallis and Spearman correlation test. Logistic 






 Ultrasonogram was performed for 389 patients. Cases managed 
conservatively and the post thyroidectomy PTC patients on surveillance, who 
did not have biochemical, radiological evidence of disease recurrence were 
eliminated from the study. The data of 350 patients was taken for analysis. 
There were 45 (12.9%) males and 305 (87.1%) female patients. The age group 
varied between 11 and 75 years. The mean age of presentation was 39.45 years.  
 The clinical profile of the study group comprised of 
Multi nodular goiter  222 
Solitary nodule    82 
Diffuse toxic goiter      5 
Toxic MNG     38 
Recurrent goiter      3 
 Of the 350 patients, 93 patients were diagnosed to have malignancy by 
histopathology. In this there were 79 (84.9%) females and 14 (15.1%) males. 
The age distribution of the malignant population was 11-75 yrs and the mean 
age of presentation was 43.45 years. (Figure 4). 5 of them had vocal cord palsy 
preoperatively. The clinical profile of 93 patients was 
 Multi nodular goitre  53 
 Solitary nodule thyroid 32 
 Toxic MNG     3 
 Recurrence / Metastasis    5   
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 The pathological profile of the patients included. 
 Papillary Ca   86 
 Medullary Ca  3 
 Metastatic Medullary Ca 2 
 Metastatic Pap Ca  2 
 The 86 cases included  
 Conventional type  36 
Follicular variant  28 
 Micropapillary Ca  19 
 Anaplastic variant   1 
 Clear cell variant  1 
 Tall cell variant  1 
 It was multicentric in 21 cases. The variety of PTC in multicentric cases 
was 
 Conventional type in  13 
 Follicular variant in  8 
The pathology associated with PTC in the opposite lobe was 
 Nodular colloid goiter  48 
 Thyroiditis    24 
 Normal    10 
 Nodular hyperplasia   4 
SPUS, RPUS and FNAC were ranked with HPE. SPUS had the 
maximum rank with a P value of < 0.0001. The spearman correlation of all the 
three parameters is given in Table 6.  
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Table 6 : Correlation of SPUS, RPUS, FNAC against variable HPE 
 Spearman 
Correlation 
Std Error Approx. 
TC 
Significance 
SPUS 0.886 0.028 35.652 .00001 
RPUS 0.524 0.053 11.474 .00001 
FNAC 0.405 0.052 8.258 .00001 
 
 
Test statistics for the three parameters SPUS, RPUS and FNAC with 
grouping variable HPE by Kruskal Wallis test are tabulated in Table 7  
(Page No.71). 
 The Spearman correlation for SPUS was 0.886 (P < 0.0001). There were 
11 false positive cases of SPUS and 5 false negative cases. 
 The cross tabulation between SPUS findings and HPE are summarized 
in Table 8. 
Table 8 :  Comparison of SPUS findings with HPE 
  





Count 246 5 251 
% within Gross SPUS 98.0% 2.0% 100.0% 
Malignant 
Count 11 88 99 
% within Gross SPUS 11.1% 88.9% 100.0% 
Total 
Count 257 93 350 




 The sensitivity, specificity, positive predictive value, negative predictive 
value of SPUS are 98.53%, 95.72%, 96.81% and 98.00% respectively. 
 The Spearman correlation for RPUS against HPE was 0.524. There were 
13 false positive cases and 47 false negative cases by RPUS. The cross 
tabulation of RPUS  findings and pathologic diagnoses are given in Table 9. 
Table 9 :  Cross tabulation of RPUS against variable HPE 
  
 Gross HPE 
Total 
  
 Benign Malignant 
Gross RPUS Benign Count 244 47 291 
% within Gross RPUS 83.8% 16.2% 100.0% 
Malignant Count 13 46 59 
% within Gross RPUS 22.0% 78.0% 100.0% 
Total Count 257 93 350 
% within Gross RPUS 73.4% 26.6% 100.0% 
 
 The sensitivity, specificity, positive predictive value, negative predictive 
value of RPUS are 86.05%, 94.94%, 95.19% and 83.8% respectively. 
Excluding the indeterminate, there were 57 false negatives and 10 false 
positives with FNAC. 1 case reported as indeterminate on FNAC turned out to 





Table 10 : Comparison of FNAC findings with HPE 
 HPE  
FNAC Benign Malignant Total 
Benign 240 57 297 
Malignant 10 35 45 
Indeterminate 7 1 8 
Total 257 93 350 
  
The sensitivity, specificity, positive predictive value and negative 
predictive value for FNAC are 82.18%, 95.62%, 96.11% and 81.08%  with the 
indeterminate group excluded from data. 
 The sensitivity and specificity of all three modalities - SPUS RPUS and 
FNAC are shown in Table 11. 
Table 11 :Comparison of sensitivity and specificity of SPUS, RPUS, FNAC 
 SPUS RPUS FNAC 
Sensitivity 98.53% 86.05% 82.18% 
Specificity 95.72% 94.94% 95.62% 
Positive Predictive Value 96.81% 95.9% 96.11% 
Negative Predictive Value 98.00% 83.8% 81.08% 
 
 The sensitivity and negative predictive value of SPUS is higher than 
RPUS & FNAC, while the specificity and positive predictive value are high for 
RPUS and FNAC showing that the surgeon tends to over diagnose malignancy. 
  The incidence of nodule characteristics – echogenicity, margins and 
calcifications is shown in Table 12. 
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Table 12 : Distribution of Nodule Characteristics in Benign and 
Malignant lesions 
Variable Benign Malignant 
Hypoechoic 113 (43.8%) 31 (33.7%) 
Heteroechoic 40 (15.5%) 57 (62%) 
Isoechoic 99 (38.4%) 4 (4.3%) 
Hyperechoic 6 (2.3%) 0 (0%) 
Regular margins 203 (78.7%) 29 (31.5%) 
Irregular margins 15 (5.8%) 62 (67.4%) 
Halo 37 (14.3%) 1 (1.1%) 
Microcalcification 7 (2.7%) 63 (68.5%) 
Coarse calcification 97 (37.6%) 54 (58.7%) 
Eggshell calcification 3 (1.2%) 1 (1.1%) 
 
 It can be extrapolated from the table that only 6 patients had 
hyperechogenicity and all 6 were benign, therefore hyperechoic nodules 
seldom occur in malignancy. 
 This univariate analysis also shows that heteroechogenicity, irregular 
margins and microcalcifications were associated with an increased risk for 
DTC compared to hypo/isoechogenicity, regular margins coarse, egg shell and 
no calcifications. 
 Association was confirmed using a multivariate model, including the 
other SPUS characteristics, (Table 13, Page No.73). 
 Heteroechogenicity (OR – 3.782 95% CI – 1.012 – 14.13 P < 0.048) 
irregular margins (OR = 11.756 95% CI – 4.939 – 27.982 P < 0.000) and 
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microcalcifications (OR = 32.567, 95% CI – 12.094 – 87.693 P < 0.000) had a 
greater association with DTC after adjustment for the other characteristics. 
 On analyzing the characteristics of the nodes, heteroechoic nodes with 
calcifications proved to be malignant always while homogenously enlarged 
nodes with loss of fatty hilum turned out to be reactive. 
Discussion 
 SPUS has become an important diagnostic modality for the evaluation 
of thyroid nodules by many endocrine surgeons. As an extension of the clinical 
examination of the neck, SPUS provides the unique opportunity to integrate 
real time ultrasound images with clinical presentation and the extensive 
knowledge of surgical neck anatomy that can be correlated later intra 
operatively. Moreover the surgeon sonographer can effectively monitor 
patients for persistent or recurrent thyroid cancer. 
 SPUS was more sensitive than RPUS and there was considerable 
variation between the two as shown by cross Table 14 Page No.72. 
Pitfalls of Ultrasound 
 The increase in incidence of thyroid cancer is definitely because of 
improved diagnosis of even small nodules less than 5 mm, and this has been 
made possible because of the availability of high resolution ultrasound. 
 But small lesions may be displaced by the transducer with a direct 
scanning technique and may never actually be imaged. Use of very light 
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pressure on the neck while scanning to keep the mass under the transducer and 
immobilizing the mass if palpable with fingers may prevent this. 
 An anterior mass may be overlooked because of near field artifact and 
contact problems with high resolution ultrasound, thyroidal vessels – inferior 
thyroid artery and its branches can be mistaken for small cysts in the thyroid. 
Longitudinal scanning prevents this artifact. 
A cystic component may occur in 13-26% of thyroid malignancies, but a 
predominant cystic component is still uncommon, but predominant cystic 
appearance may be mistaken for cystic change in a hyperplastic nodule. 
A parathyroid cyst may be mistaken for a thyroid cyst. 
A cystic metastatic node or an abnormal lymph node adjacent to the 
thyroid may be mistaken for a benign thyroid nodule, especially if they are 
calcified. 
US characteristics of AITD especially Graves include enlargement of 
the thyroid with reduced echogenicity, heterogeneity and hypervascularity. 
Large nodular infiltrative  malignancy may also have these features, and can be 
mistaken for AITD especially when associated with destructive thyroiditis or 
vice a versa. 
Benign follicular adenomas can have a heteroechoic appearance with 
calcifications and can be mistaken for malignancy. Microcalcifications which 
are pathognomonic of papillary carcinoma can also be present in follicular 
adenomas and Hashimoto’s thyroiditis and can be misinterpreted as 
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malignancy. Coarse calcifications can be present in longstanding malignancy 
and in benign degenerative disorders. Egg shell calcifications though 
predominantly seen in benign lesions can present in malignancy. 
 Although hypoechogenicity is an established parameter in detecting 
AITD, it has poor specificity in the morbidly obese, where hypoechogenicity 
was present in 64.8% of clinically and biochemically euthyroid patients with 
BMI > 4048. 
 When diffuse thyroid abnormalities are present, detection of focal 
nodules particularly thyroid carcinoma is more difficult.38 A solid hypo-echoic 
papillary carcinoma could be masked in a heterogenous thyroid gland 
containing pseudonodules from lymphocytic infiltrates and fibrosis. Though all 
types of calcification – fine, coarse and egg shell, can be seen in cases with 
coexistent hashimoto’s, the frequency of psammoma bodies is lower, whereas 
the presence of dense calcifications is higher in patients with Hashimoto’s 
when compared with a malignancy in a normal thyroid. 
 Not only can the parenchymal heterogenicity of Hashimoto’s leads to 
false negative studies, false positive results can also occur when a nodule is 
perceived within surrounding heterogenous parenchyma. 
Thus it becomes evident that single sonological feature correlates poorly 
with malignancy and a constellation of features is a better predictor, especially 
when performed by a clinician – surgeon who evaluates the nodule not only 
sonologically, but also clinically. However pattern analysis only points to the 
possibility of malignancy, but does not give tissue proof unlike FNAC. 
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 The wide variations in the sonographic findings between the radiologist 
and surgeon could be because of overlap of sonographic features. Even among 
experienced ultrasonographers concordance of USG characteristics is far from 
100%.63 So it is expected that similar if not greater discrepancies would exist 
between the interpretations of the surgeon and radiologist. 
 Armed with full understanding of pathophysiology the surgeon can 
more aptly make decisions regarding which lesions are suspicious. 
 While imaging the lymph nodes the fatty hilum may not be conspicuous 
in benign reactive nodes when small and homogenous nodes without the hilar 
shadow may be reported as malignant nodes. Similarly the heteroechogenicity 
and peripheral shift of the fatty hilum may not be evident in small malignant 
nodes in the early stage of infiltration and may be interpreted as benign. 
 Heteroechogenicity irregular borders and microcalcifications had a 
greater association with DTC after adjustment for the other characteristics. 
Comparing the nodule characteristics of the present study with the study of 
Jabiev et al3., hypoechogenicity had a significant correlation in the other study 
while heteroechogenecity was significant in the present study. The table 




Table 15 : Comparison between multivariate analysis of the nodule 
characteristics of the present study with other SPUS 
SPUS characteristics OR 95% CI P Value 
Present study Hypochogenecity 3.100 0.93 – 10.3 0.065 
 Heteroechogenecity 3.782 1.01 – 14.13 0.048 
Irregular margins 11.756 4.94 – 27.98 0.000 
Microcalcifications 32.567 12.09 – 87.07 0.000 
Jabiev et al.    
Hypochogenecity 3.83 1.61 – 9.09 0.002 
Irregular margins 2.9 1.2 – 6.98 0.018 
Microcalcifications 2.74 1.1 – 6.87 0.031 
Domniquez et al.    
Hypoechogenecity  4.7 2.8 – 8 0.04 
Irregular margins 4.3 2.8 – 6.5 0.02 
Microcalcifications 6.6 4.4 – 9.9 0.01 
 
 In case of indeterminate cytology, the surgeon can choose to operate if 
these ultrasound characteristics – Heteroechogenecity, Irregular margins and 
Microcalcifications are present. 
Pitfalls of cytology 
 FNA of thyroid has become an important tool in evaluating thyroid 
nodules and the definitively positive and negative diagnoses have high 
sensitivity and specificity. Though FNAC gives a preoperative diagnosis of 
thyroid cancer it has a high false negative rate especially if the nodule is greater 
than 4 cm. From the cytopathologic perspective, most thyroid cancers are low 
grade and have pathologic features that overlap with other benign hyperplastic 
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or neoplastic nodules. These characteristics combined with the technical 
challenges associated with procuring an adequate thyroid sample highlight the 
difficulties in diagnostic thyroid cytology. Comparison of FNAC and HPE 
Findings are shown in Table 16 (Page No.75).  
 In benign lesions, cytologic73 misclassification does not harm the 
patients. Thyroiditis can be reported as colloid goiter and suspected neoplasm 
and adenomatoid nodules can prove to be thyroiditis, because Hurthle cells can 
be derived from a variety of lesions, commonly nodular goiter, chronic 
lymphocytic thyroiditis and follicular neoplasm of Hurthle cell type. 
 In malignancy, the negative predictive value of a screening test should 
be ideally 100%. In reality this is not possible. 
 The commonly cited Pitfalls are, 
Cytology does not pick up capsular or vascular invasion. Hence 
follicular carcinomas cannot be distinguished from adenomas. The same is true 
with Hurthle cell adenoma and carcinoma. Artifactual bubbling in normal 
nuclei may be confused with intranuclear holes in papillary carcinoma. Non 
neoplastic atypia in Hashimoto’s thyroiditis, post irradiation thyroiditis and 
dyshormonogenic goiter can be mistaken for malignancy. 
 In multinodular goiter, the exact location of the malignant process can 
be missed by the needle and thus result in a false negative state. 
 The cystic degenerations in a poorly differentiated carcinoma may be 
misclassified as a benign lesion and so might account for false negative smears. 
63 
 
 The polymorphous lymphocytes and epithelial cells in a low grade 
lymphoma and a well differentiated papillary carcinoma arising in the 
background of thyroiditis can be reported as lymphocytic thyroiditis.39 
 Graves disease shows large sheets of hyperplastic cells with abundant 
cytoplasm. Oncocytes and lymphocytes may be present in the background. But 
it should characteristically lack nuclear atypia and microfollicular component. 
But this can also be seen in a follicular adenoma, follicular carcinoma and 
follicular variant of papillary carcinoma. Yet another false negative rate can be 
seen with follicular variant of papillary carcinoma where the subtle nuclear 
changes may not be detected on cytology and the lack of papillae may be 
difficult to distinguish from follicular neoplasms. Wide inter observer 
variations involve the follicular variant of papillary carcinoma and oncocytic 
variant of papillary carcinoma. 
 Thus the reasons for the wide variations in reporting malignancy can be 
multifactorial and can be due to patient and regional characteristics, operator 
and processing techniques, surgical pathology analysis and diagnostic 
threshold. 
 By combining clinical, ultrasonographic immunohistochemical markers, 
it is possible to overcome the pitfalls of FNAC. 
Pitfalls of Histopathology 
 Compared with radiologist performed ultrasound and FNAC, surgeon 
performed ultrasound findings correlated with HPE report. 
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 However 11 cases reported as malignant on SPUS turned out to be 
benign on HPE (false positive) and 5 cases reported as benign turned out to be 
malignant (false negative). Table 17 shows the comparative diagnosis in false 
positive cases and table 18 shows the comparative diagnoses in false negative 
cases. Cross tabulation between SPUS vs HPE, Table 19, Page No.76.  
Table 17 : Cases malignant on SPUS, benign on HPE (False positive) 
 
S.No. SPUS RPUS FNAC HPE 
1. Pap Ca Colloid Colloid OAH 
2. Pap Ca Colloid Colloid OAH 
3. Pap Ca Colloid Colloid Papillary hyperplasia 
4. Pap Ca MNG Papillary hyperplasia Papillary hyperplasia 
5. Pap Ca MNG Colloid Papillary hyperplasia 
6. Pap Ca SNT Colloid Papillary hyperplasia 
7. Pap Ca Colloid Colloid Papillary hyperplasia 
8. Pap Ca Pap Ca Pap Ca Papillary hyperplasia 
9. Pap Ca Colloid Colloid Papillary hyperplasia 




Pap Ca Mets Reactive nodes 





Table 18 : Cases benign on SPUS, malignant on HPE (False negative) 
 
S.No. SPUS RPUS FNAC HPE 
1. Colloid Colloid NCG Pap Ca 
2. Thyroiditis MNG Thyroiditis Pap Ca (F.V) 
3. Thyroiditis Pap Ca Colloid Pap Ca 
4. Colloid MNG Colloid Pap Ca (F.V) 
5. Colloid Pap Ca Colloid Pap Ca (F.V) 
 
 
 A variety of thyroid lesions can exhibit papillae and the differential 
diagnosis includes nodular goiter, follicular adenoma with papillary 
hyperplasia, toxic follicular adenoma Hurthle cell adenoma carcinoma with 
papillae, medullary carcinoma – papillary variant, Hashimoto’s thyroiditis. 
 The papillae encountered in benign lesions are usually broad and contain 
follicles in the cores. Delicately branching papillae can occasionally be present. 
But the nuclei are regular, non-crowded, basally situated, dark, round nuclei 
resembling “beads on a string,” in contrast to haphazardly oriented pale nuclei 
of papillary carcinoma.46 
 Fibrovascular core may be seen in thyroiditis and toxic follicular 
adenoma. The typical nuclear features of papillary carcinoma are lacking, 
though nuclear clearing – a preparation artifact may be seen; more in 
Hashimoto’s thyroiditis, calcified colloid mimicking psammoma bodies may be 
seen. Occasional nuclear grooves can be present in Hurthle cell adenoma. 
 The diagnosis given by SPUS in the five false negative cases were, 
thyroiditis, in 2 patient colloid goiter in 3 patients. 
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 All five cases showed papillary projections with occasional nuclear 
clearing, but nuclear crowding a characteristic feature of papillary carcinoma 
was absent. One case, a case of recurrent toxic MNG, showed scalloping of 
colloid apart from the papillary projections. 
 The differential diagnosis of encapsulated cellular follicular patterned 
lesion includes adenomatoid / hyperplastic nodule, follicular and Hurthle cell 
adenoma, follicular and Hurthle cell carcinoma, follicular variant of papillary 
carcinoma and follicular variant of medullary carcinoma. 
 The distinction between follicular carcinoma and follicular adenoma 
rests on identification of vascular or capsular invasion. Clinically there are 
instances where cases undergoing hemithyroidectomy for follicular adenoma 
later present with distant metastases. This could be due to the fact that sections 
did not include the site of vascular or capsular invasion. Is it really worthwhile 
to include more sections in search of capsular invasion in a slow growing 
tumour has been debated for long. 
 Morphologic criteria for the distinction between adenomatoid nodule 
and follicular adenoma are not well defined. Nonetheless it does not matter 
whether the nodule is labelled one way or the other. 
 The most difficult diagnostic problem is when there are some pale or 
clear nuclei for which the differential diagnosis is between follicular variant of 
papillary carcinoma and follicular adenoma. This is because some papillary 
carcinomas may not exhibit all the characteristic nuclear features while some 
follicular adenomas can exhibit focal clear or grooved nuclei. 
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 The reproducibility in the diagnosis of encapsulated follicular lesions 
that show focal and or incompletely developed nuclear features of papillary 
carcinoma is very low.12 The follicular variant must show typical nuclear 
features of papillary carcinoma. If clear nuclei are confined to the central 
portion of the tumour but are absent in the peripheral portion, the most likely 
explanation is a follicular adenoma or adenomatoid nodule with delayed 
fixation, resulting in artifactual blowing up and clearing of the nuclei. 
 The differential diagnoses of cells rich in oncocytes includes Hurthle 
cell adenoma/carcinoma, oncocytic variant of PTC and medullary carcinoma, 
oncocytic nodules in Hashimoto’s thyroiditis, adenomatoid nodule with 
oncocytic cells. Distinction between oncocytic variant of PTC and Hurthle cell 
adenoma/carcinoma is problematic. The oncocytic variant of PTC may lack 
papillae and nuclear crowding may not be evident as a result of the abundance 
of cytoplasm. On the other hand, in Hurthle cell adenoma/carcinoma some 
nuclei may show grooving or even rare intranuclear inclusions and the calcified 
colloid may mimic psammoma bodies.2 
 Thus it becomes evident that though histopathology is the gold standard 
in the diagnosis of tumours, it has its own grayzones and areas of overlap 
where a pathologist overdiagnoses malignancy using lax criteria to avoid being 
sued for missing a malignancy and another pathologist adopts a conservative 
policy because the prognosis of some of the variants is so good and no harm is 





 Ultrasound has definitely revolutionsed the management of thyroid 
nodules. When a surgeon performs it, he gains more real time information and 
this information has altered the management plan. Even microcarcinomas with 
false negative FNAC have been identified by SPUS. 
 SPUS had a higher spearman correlation and Kruskal Wallis score when 
tested against HPE, along with RPUS and FNAC. The sensitivity, specificity, 
positive predictive value and negative predictive value of the three modalities 
is shown below in the Table. 
 SPUS RPUS FNAC 
Sensitivity 98.53% 86.05% 82.18% 
Specificity 95.72% 94.94% 95.62% 
Positive Predictive Value 96.81% 95.9% 96.11% 
Negative Predictive Value 98.00% 83.8% 81.08% 
 
 When nodule characteristics were correlated with malignancy by a 
multivariate analysis, heteroechogenicity, (OR – 3.782, CI – 1.012 – 14.13 P < 
0.048) irregular margins (OR – 11.756 95% CI – 4.939 – 27.982, P < 0.000) 
and microcalcifications (OR – 32.567, 95% CI – 12.094 – 87.693, P < 0.000) 
had a greater association with DTC after adjustment for the other 
characteristics. 
 Hypoechogenicity had less significance in variation with other studies. 
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 However there are overlapping features in all three diagnostic modalities 
– sonography, FNAC and histopathology especially in identifying the 
oncocytic and follicular variants of PTC. The surgeon scores over the 
radiologist as he is more familiar with the anatomy of the region, more focused 
on exclusively scanning the thyroid, and correlates the sonological findings 
with clinical features. Moreover, the surgeon sonographer can effectively 
monitor patients for persistent or recurrent thyroid cancer. 
Complete tesslation between the surgeon and the pathologist is 
mandatory for the benefit of the patient, to overcome the overlap zones. It will 
be more apt if the pathologist visits the operating room when the surgeon briefs 
on the clinical evaluation of the patient and the pathologist gains first hand 
information by grossing the specimen before it is formalin fixed. The surgeon 
can visit the pathology suite to discuss, understand the diagnostic challenges 
and review the diagnosis with the pathologist before final reporting is done. 
This avoids the misinterpretation and misrepresentation of samples. 
FNAC and ultrasound are useful clinical adjuncts which aid in the 
preoperative diagnosis of malignancy, and do not replace clinical judgement. 








FIGURE 4  







Table 7  : Ranks and Kruskal Wallis Test Scores of SPUS, RPUS, 
FNAC against variable HPE 
Ranks 
 Gross HPE N Mean Rank 
Gross SPUS Benign 257 133.49 
Malignant 93 291.59 
Total 350  
Gross RPUS Benign 257 154.85 
Malignant 93 232.56 
Total 350  
Gross FNAC Benign 257 161.03 
Malignant 93 215.48 









Chi-Square 273.985 95.795 51.116 
df 1 1 1 
Asymp. Sig. .000 .000 .000 
a. Kruskal Wallis Test 





Table 14 : SPUS * RPUS Crosstabulation 
   rpus 
Total 
   pap ca colloid thyroiditis Adenoma pap ca mets med ca med ca 
mets snt mng 
spus pap ca Count 38 23 0 2 0 0 0 7 20 90 
% within spus 42.2% 25.6% .0% 2.2% .0% .0% .0% 7.8% 22.2% 100.0% 
colloid Count 10 82 2 4 0 0 0 10 19 127 
% within spus 7.9% 64.6% 1.6% 3.1% .0% .0% .0% 7.9% 15.0% 100.0% 
thyroiditis Count 1 21 51 1 0 0 0 2 17 93 
% within spus 1.1% 22.6% 54.8% 1.1% .0% .0% .0% 2.2% 18.3% 100.0% 
adenoma Count 2 8 0 5 0 0 0 7 9 31 
% within spus 6.5% 25.8% .0% 16.1% .0% .0% .0% 22.6% 29.0% 100.0% 
pap ca mets Count 0 0 0 0 4 0 0 0 0 4 
% within spus .0% .0% .0% .0% 100.0% .0% .0% .0% .0% 100.0% 
med ca Count 0 0 1 0 0 2 0 0 0 3 
% within spus .0% .0% 33.3% .0% .0% 66.7% .0% .0% .0% 100.0% 
med ca mets Count 0 0 0 0 0 0 2 0 0 2 
% within spus .0% .0% .0% .0% .0% .0% 100.0% .0% .0% 100.0% 
Total Count 51 134 54 12 4 2 2 26 65 350 
% within spus 14.6% 38.3% 15.4% 3.4% 1.1% .6% .6% 7.4% 18.6% 100.0% 
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Table 13  : Multivariate analysis of nodule characteristics 
 
 





hypo(1) 19.602 15262.909 .000 1 .999 3.257E8 .000 . 
hetero(1) 19.801 15262.909 .000 1 .999 3.976E8 .000 . 
iso(1) 18.669 15262.909 .000 1 .999 1.282E8 .000 . 
reg(1) .880 1.382 .406 1 .524 2.411 .161 36.191 
irreg(1) 3.195 1.398 5.223 1 .022 24.409 1.576 378.022 
halo(1) -.583 1.793 .106 1 .745 .558 .017 18.729 
fine(1) 3.521 .518 46.186 1 .000 33.828 12.253 93.393 
coarse(1) .147 .441 .111 1 .739 1.159 .488 2.750 
eggshell(1) .893 1.589 .316 1 .574 2.442 .109 54.948 
Constant -22.940 15262.909 .000 1 .999 .000   
Step 2a 
hypo(1) 19.602 15277.783 .000 1 .999 3.257E8 .000 . 
hetero(1) 19.810 15277.783 .000 1 .999 4.012E8 .000 . 
iso(1) 18.658 15277.783 .000 1 .999 1.268E8 .000 . 
reg(1) 1.235 .893 1.914 1 .166 3.440 .598 19.792 
irreg(1) 3.547 .932 14.496 1 .000 34.713 5.591 215.527 
fine(1) 3.530 .517 46.569 1 .000 34.119 12.380 94.036 
coarse(1) .131 .438 .089 1 .765 1.140 .483 2.691 
eggshell(1) .887 1.590 .311 1 .577 2.428 .108 54.750 
Constant -23.294 15277.783 .000 1 .999 .000   
Step 3a 
hypo(1) 19.634 15229.710 .000 1 .999 3.364E8 .000 . 
hetero(1) 19.866 15229.710 .000 1 .999 4.244E8 .000 . 
iso(1) 18.661 15229.710 .000 1 .999 1.271E8 .000 . 
reg(1) 1.238 .893 1.922 1 .166 3.450 .599 19.866 
irreg(1) 3.582 .925 14.986 1 .000 35.935 5.861 220.336 
fine(1) 3.509 .512 46.985 1 .000 33.411 12.251 91.123 
eggshell(1) .795 1.571 .256 1 .613 2.215 .102 48.144 
Constant -23.268 15229.710 .000 1 .999 .000   
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hypo(1) 19.551 15151.254 .000 1 .999 3.096E8 .000 . 
hetero(1) 19.820 15151.254 .000 1 .999 4.052E8 .000 . 
iso(1) 18.592 15151.254 .000 1 .999 1.187E8 .000 . 
reg(1) 1.248 .893 1.953 1 .162 3.484 .605 20.069 
irreg(1) 3.600 .925 15.139 1 .000 36.601 5.969 224.418 
fine(1) 3.486 .509 46.852 1 .000 32.660 12.036 88.620 
Constant -23.194 15151.254 .000 1 .999 .000   
Step 5a 
hypo(1) 1.088 .620 3.083 1 .079 2.969 .881 10.003 
hetero(1) 1.362 .675 4.076 1 .043 3.905 1.041 14.655 
reg(1) 1.259 .897 1.971 1 .160 3.521 .607 20.415 
irreg(1) 3.563 .925 14.844 1 .000 35.264 5.757 216.015 
fine(1) 3.495 .509 47.082 1 .000 32.934 12.138 89.362 
Constant -4.728 1.013 21.770 1 .000 .009   
Step 6a 
hypo(1) 1.131 .613 3.406 1 .065 3.100 .932 10.307 
hetero(1) 1.330 .672 3.913 1 .048 3.782 1.012 14.129 
irreg(1) 2.464 .442 31.026 1 .000 11.756 4.939 27.982 
fine(1) 3.483 .505 47.503 1 .000 32.567 12.094 87.693 
Constant -3.601 .546 43.437 1 .000 .027   




Table 16 : FNAC * HPE Crosstabulation 
 
   Hpe 
Total 






fnac pap ca Count 28 5 2 1 0 0 0 1 0 0 37 
% within fnac 75.7% 13.5% 5.4% 2.7% .0% .0% .0% 2.7% .0% .0% 100.0% 
colloid Count 47 114 51 22 0 1 0 6 3 0 244 
% within fnac 19.3% 46.7% 20.9% 9.0% .0% .4% .0% 2.5% 1.2% .0% 100.0% 
thyroiditis Count 7 3 34 2 0 0 0 0 0 0 46 
% within fnac 15.2% 6.5% 73.9% 4.3% .0% .0% .0% .0% .0% .0% 100.0% 
adenoma Count 1 0 0 1 0 0 0 0 0 0 2 
% within fnac 50.0% .0% .0% 50.0% .0% .0% .0% .0% .0% .0% 100.0% 
pap ca 
mets 
Count 0 0 0 0 3 0 0 0 0 1 4 
% within fnac .0% .0% .0% .0% 75.0% .0% .0% .0% .0% 25.0% 100.0% 
med ca Count 0 0 0 0 0 2 0 0 0 0 2 
% within fnac .0% .0% .0% .0% .0% 100.0% .0% .0% .0% .0% 100.0% 
med ca 
mets 
Count 0 0 0 0 0 0 2 0 0 0 2 
% within fnac .0% .0% .0% .0% .0% .0% 100.0% .0% .0% .0% 100.0% 
follicular 
neoplasm 
Count 0 2 0 4 0 0 0 0 0 0 6 
% within fnac .0% 33.3% .0% 66.7% .0% .0% .0% .0% .0% .0% 100.0% 
papillary 
hyperplasia 
Count 2 0 3 1 0 0 0 1 0 0 7 
% within fnac 28.6% .0% 42.9% 14.3% .0% .0% .0% 14.3% .0% .0% 100.0% 
Total Count 85 124 90 31 3 3 2 8 3 1 350 




Table 19 : HPE * SPUS Crosstabulation 
   
spus 
Total 
pap ca colloid thyroiditis Adenoma pap ca mets med ca med ca mets 
hpe pap ca Count 80 4 1 0 0 0 0 85 
% within hpe 94.1% 4.7% 1.2% .0% .0% .0% .0% 100.0% 
colloid Count 0 106 12 6 0 0 0 124 
% within hpe .0% 85.5% 9.7% 4.8% .0% .0% .0% 100.0% 
thyroiditis Count 0 8 80 2 0 0 0 90 
% within hpe .0% 8.9% 88.9% 2.2% .0% .0% .0% 100.0% 
adenoma Count 1 8 0 22 0 0 0 31 
% within hpe 3.2% 25.8% .0% 71.0% .0% .0% .0% 100.0% 
pap ca mets Count 0 0 0 0 3 0 0 3 
% within hpe .0% .0% .0% .0% 100.0% .0% .0% 100.0% 
med ca Count 0 0 0 0 0 3 0 3 
% within hpe .0% .0% .0% .0% .0% 100.0% .0% 100.0% 
med ca mets Count 0 0 0 0 0 0 2 2 
% within hpe .0% .0% .0% .0% .0% .0% 100.0% 100.0% 
papillary hyperplasia Count 7 0 0 1 0 0 0 8 
% within hpe 87.5% .0% .0% 12.5% .0% .0% .0% 100.0% 
oncocytic adenomatoid 
hyperplasia 
Count 2 1 0 0 0 0 0 3 
% within hpe 66.7% 33.3% .0% .0% .0% .0% .0% 100.0% 
reactive nodes Count 0 0 0 0 1 0 0 1 
% within hpe .0% .0% .0% .0% 100.0% .0% .0% 100.0% 
Total Count 90 127 93 31 4 3 2 350 
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MASTER CHART 
S.No. Name Age S IP No. SPUS RPUS FNAC HPE Echo Rt 
Echo 
Lt Nodule Rt 
Nodule 
Lt Calcifications Nodes 
1. alamelu 55 f 54678 pap ca pap ca colloid pap ca hetero iso no hetero irr fine lt mn 
2. sarala 35 f 54778 colloid colloid colloid colloid hetero hetero hypo reg iso reg coarse no 
3. muniammal 30 f 54783 pap ca pap ca pap ca pap ca iso hypo iso reg hetero irr fine no 
4. vanitha 23 f 52694 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso halo no no no 
5. munishwari 37 f 53743 pap ca pap ca colloid pap ca iso iso hyper reg hetero irr fine coarse no 
6. sivagami 32 f 52696 pap ca pap ca pap ca pap ca iso iso iso halo hetero irr fine no 
7. sumathy 29 f 52752 colloid colloid colloid colloid iso iso no cystic reg no no 
8. fathima 48 f 50487 colloid colloid colloid colloid hetero hetero hypo reg iso reg no no 
9. jayaseeli 25 f 61137 colloid colloid colloid colloid iso iso hypo reg iso reg no no 
10. subashini 29 f 56959 pap ca snt pap ca pap ca iso hetero no hetero irr fine coarse lt bn 
11. kanniammal 40 f 56934 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no no no no 
12. andal 48 f 56986 colloid pap ca colloid colloid hetero hetero hypo reg hypo reg no no 
13. alamelu 40 f 55849 colloid pap ca colloid colloid iso iso cystic reg no no no 
14. subbulakshmi 20 f 56940 adenoma pap ca follicular 
neoplasm adenoma hypo iso iso halo no no no 
15. jayakodi 50 f 55874 colloid pap ca colloid colloid iso iso cystic reg cystic reg no no 
16. vijayalaxmi 55 f 55789 thyroiditis colloid colloid colloid hetero hetero iso reg iso reg coarse no 
17. illayaraja 19 m 49470 adenoma colloid colloid colloid iso iso hyper halo cystic reg no no 
18. anandababu 30 m 55928 thyroiditis thyroiditis colloid thyroiditis hypo hypo cystic reg cystic reg coarse no 
19. sathish 23 m 52731 colloid mng colloid colloid iso iso iso reg iso reg coarse no 
20. sindhu 30 f 60241 colloid colloid colloid colloid iso iso hypo reg iso reg no no 
21. maragatham 27 f 62407 colloid colloid colloid colloid iso iso cystic irr iso reg no no 
22. kumari 24 f 59138 colloid mng colloid colloid iso iso no no no no 
23. maria selvi 50 f 59137 colloid colloid colloid colloid absent iso no hypo reg coarse lt bn 
24. jayashree 41 f 59528 colloid mng colloid colloid iso iso hyper reg hyper reg no no 
25. rengammal 40 f 60276 colloid colloid papillary hyperplasia thyroiditis iso iso hypo reg iso reg coarse no 
26. amsaveni 46 f 66779 colloid adenoma colloid colloid iso iso cystic reg cystic reg no no 
27. amala 23 f 68713 adenoma adenoma colloid colloid iso iso no iso halo no no 
  
28. rajeswari 65 f 64619 colloid colloid follicular 
neoplasm colloid iso iso cystic reg hypo reg coarse no 
29. mari 35 f 60234 colloid mng colloid colloid iso iso hypo reg hypo reg no no 
30. jaya 50 f 55874 colloid mng colloid colloid iso iso hyper reg hyper reg no no 
31. annamayil 35 f 64654 thyroiditis mng colloid thyroiditis hypo hypo iso reg iso reg no no 
32. thenmozhi 17 f 66715 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
33. nithya 26 f 76475 colloid colloid colloid thyroiditis iso iso cystic reg cystic reg no no 
34. emmanuel 14 m 55875 adenoma snt follicular 
neoplasm adenoma iso iso iso halo no no no 
35. devaki 45 f 78934 colloid colloid colloid colloid iso iso cystic irr no coarse no 
36. panjali 55 f 65845 thyroiditis mng thyroiditis thyroiditis iso iso hyper reg hyper reg no no 
37. kasthuri 63 f 76418 colloid colloid colloid colloid iso iso cystic irr cystic reg coarse no 
38. prema 45 f 76442 colloid colloid colloid colloid iso iso no hetero reg coarse lt bn 
39. govindammal 45 f 76416 pap ca mng colloid pap ca iso iso no hetero reg fine no 
40. mangayarkarasi 65 f 77670 pap ca mng colloid pap ca iso iso hetero irr cystic reg fine coarse rt bn 
41. govindan 29 m 76543 colloid colloid colloid colloid iso iso iso halo cystic reg no no 
42. sundari 35 f 78914 colloid snt pap ca colloid iso iso no cystic reg no no 
43. girija 40 f 78919 med ca thyroiditis colloid med ca absent iso no no coarse cmn 
44. padmavathi 75 f 73954 pap ca pap ca colloid pap ca iso iso hypo reg hetero irr fine no 
45. vani 26 f 76403 pap ca pap ca pap ca pap ca iso iso hypo reg hetero irr fine no 
46. malliga 42 f 73908 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no no no no 
47. manjula 36 f 80131 thyroiditis thyroiditis colloid thyroiditis hypo iso hypo reg no no no 
48. maheswari 28 f 83625 med ca med ca med ca med ca iso iso no hetero irr coarse lt mn 
49. shailaja 27 f 83604 colloid mng colloid colloid iso iso no cystic reg coarse no 
50. indumathy 39 f 83635 colloid mng colloid colloid iso iso hypo halo iso reg no no 
51. kasthuri 48 f 80167 colloid mng colloid colloid iso iso no hetero reg coarse no 
52. arjunan 70 m 70831 pap ca mets pap ca mets pap ca mets pap ca mets absent absent no no fine rt mn 
53. raja 35 m 83607 colloid thyroiditis colloid colloid iso iso no no no no 
54. babu 42 m 83641 colloid colloid colloid colloid iso iso hetero reg no no no 
55. prem kumar 24 m 76435 thyroiditis colloid colloid thyroiditis hypo hypo iso reg iso reg no bbn 
56. renu 48 f 83642 pap ca pap ca pap ca pap ca iso iso hetero irr no fine coarse lt bn 
57. shobana 22 f 85777 colloid snt colloid adenoma iso iso iso reg no no no 
58. amsa 40 f 85793 thyroiditis colloid colloid thyroiditis iso hypo no no no no 
59. chinnakuppan 40 m 87004 pap ca pap ca pap ca pap ca iso iso hetero irr hypo irr fine coarse rt mn lt 
  
bn 
60. kanchana 42 f 83676 colloid thyroiditis colloid colloid iso iso iso reg cystic reg no no 
61. malliga 52 f 86951 colloid snt colloid colloid absent iso no no no no 
62. kalaiselvi 35 f 88087 colloid snt colloid colloid iso iso iso reg no no no 
63. manonmani 40 f 88108 thyroiditis thyroiditis colloid thyroiditis hypo hypo no iso reg no bbn 
64. muthulakshmi 47 f 86980 colloid colloid colloid colloid absent iso no cystic irr coarse lt bn 
65. saritha 25 f 86954 thyroiditis colloid colloid thyroiditis hypo hypo no no no bbn 
66. pushpalatha 44 f 93035 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
67. kalaiselvi 35 f 92996 thyroiditis mng colloid thyroiditis iso hypo no no no no 
68. vanitha 46 f 94128 thyroiditis mng colloid colloid iso hypo iso reg iso no no 
69. kavitha 30 f 94057 colloid colloid colloid colloid absent iso no no no no 
70. shanthi 29 f 92971 thyroiditis colloid colloid thyroiditis hypo iso no no no no 
71. malliga 41 f 94079 pap ca pap ca colloid pap ca iso iso iso reg hetero irr fine no 
72. manimegalai 62 f 93004 pap ca colloid colloid pap ca iso iso cystic irr hetero irr fine no 
73. glory 51 f 97263 thyroiditis thyroiditis colloid thyroiditis hypo iso iso reg iso reg no no 
74. zeenath 33 f 97270 thyroiditis thyroiditis colloid thyroiditis hetero hetero no no no no 
75. kantha 46 f 101362 thyroiditis colloid colloid thyroiditis iso iso no iso halo no bbn 
76. boopathi 48 f 99394 colloid colloid colloid colloid iso iso iso reg hypo reg no no 
77. fathimuthu 55 f 101362 thyroiditis pap ca colloid thyroiditis hetero hetero hypo reg cystic reg coarse no 
78. pappammal 60 f 94662 pap ca pap ca pap ca papca iso iso hetero reg hetero irr fine coarse lt mn 
79. gnanamani 55 f 98350 pap ca mng colloid pap ca iso iso iso reg hypo irr coarse no 
80. anthony 36 f 99121 colloid mng colloid colloid iso iso iso reg iso reg no no 
81. sangeetha 30 f 99414 pap ca colloid colloid pap ca iso hypo hypo irr iso reg coarse rt mn lt bn 
82. arumugam 26 m 101373 thyroiditis thyroiditis colloid thyroiditis hypo iso no no no no 
83. kokila 27 f 101342 colloid mng colloid colloid iso iso iso reg hypo reg no no 
84. navaneetham 37 f 102375 thyroiditis thyroiditis colloid thyroiditis iso hetero no hetero reg coarse no 
85. rajeswari 55 f 103438 pap ca colloid colloid pap ca iso iso hypo reg iso reg fine coarse no 
86. rekha 22 f 104419 thyroiditis thyroiditis colloid thyroiditis hypo hypo no no no no 
87. geetha 23 f 574 thyroiditis thyroiditis colloid thyroiditis hypo hypo no no no no 
88. usha 34 f 104481 colloid pap ca colloid adenoma iso iso no hetero reg comet bbn 
89. rani 53 f 535 pap ca pap ca colloid pap ca iso hypo hypo reg cystic irr fine corse bbn 
90. shantha 58 f 106332 colloid colloid colloid colloid iso hypo hyper reg cystic irr comet eggshell bbn 
91. kamsala 40 f 497 thyroiditis colloid colloid thyroiditis iso iso no no no bbn 
  
92. esther 46 f 553 thyroiditis mng colloid thyroiditis hypo iso no no no bbn 
93. rosy 30 f 559 colloid colloid colloid colloid iso iso no no no no 
94. hemalatha 12 f 1639 thyroiditis colloid colloid thyroiditis hypo iso no iso reg no no 
95. shajitha 36 f 1634 pap ca pap ca pap ca pap ca iso iso hetero irr hetero reg fine coarse no 
96. kamatchi 21 f 1628 colloid colloid colloid colloid iso iso no no no no 
97. uma 40 f 1638 thyroiditis adenoma colloid thyroiditis hypo iso no no no no 
98. malathy 43 f 1618 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero no no no no 
99. esther 46 f 145 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no no no no 
100. murugammal 32 f 2822 colloid colloid colloid colloid iso iso iso reg iso reg comet coarse no 
101. thulasi 22 f 6859 colloid colloid colloid colloid iso iso iso reg hyper reg no bbn 
102. thenmozhi 32 f 5660 colloid colloid colloid thyroiditis iso iso no no no no 
103. vasanthi 32 f 5600 pap ca colloid colloid OAH iso iso hetero irr no fine coarse bbn 
104. ponni 45 f 6815 colloid colloid colloid colloid iso iso hetero reg hetero irr coarse bbn 
105. ramani 36 f 6818 colloid colloid colloid colloid hypo iso no hetero reg comet no 
106. pushpammal 57 f 5610 pap ca colloid colloid pap ca iso iso iso reg hetero reg fine no 
107. jayaseeli 33 f 5657 thyroiditis thyroiditis colloid colloid hypo hypo no no no bbn 
108. krishnaveni 58 f 5610 pap ca pap ca colloid pap ca iso hetero hetero irr hypo reg fine no 
109. narayanan 68 m 5645 thyroiditis thyroiditis colloid colloid hetero hetero hypo irr cystic reg comet no 
110. jailani 39 f 5592 colloid colloid colloid OAH iso iso no no no no 
111. philomina 50 f 5576 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero hypo irr hypo irr no no 
112. murugammal 32 f 2036 colloid colloid colloid colloid iso iso iso reg iso reg no no 
113. sayed meera 29 f 7898 pap ca colloid colloid pap ca iso iso hypo irr no fine no 
114. mangailakshmi 55 f 7908 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero iso reg iso reg comet no 
115. suguna 39 f 7894 colloid colloid colloid colloid iso iso iso reg iso reg no no 
116. santhosh mary 33 f 9128 thyroiditis mng thyroiditis thyroiditis hypo hypo iso reg iso reg no bbn 
117. manimegalai 62 f 9304 pap ca colloid colloid pap ca iso iso hypo reg iso reg fine  coarse bbn 
118. saroja 32 f 9149 thyroiditis thyroiditis colloid thyroiditis hypo hypo iso reg iso reg no no 
119. bhuvaneshwari 32 f 9103 pap ca mng papillary hyperplasia pap ca iso iso hypo reg hetero irr fine coarse no 
120. savitri 43 f 9104 adenoma pap ca colloid adenoma iso iso iso halo no no no 
121. kokilavani 19 f 9107 adenoma snt colloid adenoma iso iso no iso halo no no 
122. karupayeammal 60 f 9112 colloid colloid colloid colloid hypo iso no iso halo no no 
123. indira 39 f 10210 pap ca mng colloid pap ca hetero hetero hypo irr no coarse no 
124. guruvammal 67 f 10228 pap ca mng colloid pap ca iso iso no hetero irr fine coarse no 
  
125. sakunthala 57 f 10203 pap ca pap ca thyroiditis pap ca iso iso hetero irr no coarse no 
126. laila 45 f 10267 colloid colloid colloid colloid iso iso iso reg iso halo no no 
127. manjula 38 f 11361 pap ca colloid colloid pap ca hetero iso hypo irr iso halo coarse no 




iso iso hetero irr no fine coarse no 
129. chitra 25 f 11423 colloid colloid colloid thyroiditis iso iso no cystic irr no no 
130. amaravathy 50 f 12489 colloid colloid colloid colloid iso iso no no coarse no 
131. sundari 25 f 12513 adenoma colloid colloid adenoma hetero hetero hypo reg no no no 
132. salomi 45 f 13739 pap ca colloid colloid papillary hyperplasia iso iso hetero reg no fine coarse no 
133. afreen 40 f 13618 thyroiditis mng colloid thyroiditis hypo hypo iso reg iso reg no no 
134. vijaya 35 f 13652 colloid adenoma colloid colloid iso iso cystic irr no coarse no 
135. vedavalli 39 f 13299 thyroiditis colloid colloid thyroiditis hypo hypo iso halo hypo reg comet coarse no 
136. arasu 35 f 13606 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero hypo reg hyper reg coarse no 
137. chandraleka 50 f 14636 pap ca snt colloid pap ca iso iso no hetero irr fine no 
138. philomina 50 f 13698 thyroiditis thyroiditis colloid thyroiditis hypo hypo no iso reg no no 
139. kumar 50 m 13716 thyroiditis thyroiditis papillary hyperplasia thyroiditis hetero hetero no no no bbn 
140. yuvaraj 41 m 13993 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
141. nagammal 26 f 11346 pap ca snt pap ca pap ca iso iso hetero reg no fine rt bn 
142. mohanasundari 24 f 11395 pap ca pap ca pap ca pap ca iso iso hetero irr no fine no 
143. suchitra 56 f 14949 pap ca colloid colloid pap ca iso iso hetero reg hetero reg coarse no 
144. mumala bee 57 f 15840 colloid mng colloid colloid iso iso cystic reg no no bbn 
145. vijaya 48 f 15849 colloid colloid colloid colloid iso iso hyper reg cystic reg comet coarse no 
146. ezhilarasi 25 f 16983 thyroiditis thyroiditis colloid thyroiditis absent hypo no no no no 
147. gajalakshmi 28 f 16980 colloid mng colloid pap ca iso iso no cystic reg no bbn 
148. kasi 58 m 16263 pap ca mng colloid pap ca iso iso no hetero irr fine coarse no 
149. kamala 54 f 18162 adenoma snt colloid adenoma iso iso iso halo no coarse no 
150. karunakaran 50 m 17668 colloid colloid follicular 
neoplasm colloid iso iso cystic reg no comet no 
151. vedavalli 39 f 19299 adenoma snt colloid adenoma iso iso iso halo hypo reg comet coarse no 
152. anbhazagan 49 m 19614 colloid colloid colloid colloid iso iso hypo reg cystic reg comet coarse no 
153. sudhadevi 25 f 20360 adenoma colloid colloid adenoma iso iso iso halo hypo halo coarse no 
  
154. kokilaveni 19 f 20367 adenoma snt colloid adenoma iso iso no iso halo no no 
155. murugammal 32 f 20364 pap ca mng colloid papillary hyperplasia iso iso hypo reg cystic reg coarse no 
156. indira 42 f 20363 thyroiditis thyroiditis thyroiditis thyroiditis iso hypo hypo reg no coarse no 
157. mangammal 40 f 19374 thyroiditis colloid colloid thyroiditis hetero hetero hypo reg hypo reg no no 
158. sundari 40 f 20411 adenoma snt colloid adenoma iso iso iso halo no no no 
159. buthamathi 51 f 21576 colloid colloid colloid colloid iso iso hyper reg hypo reg coarse no 
160. mariyammal 35 f 21606 pap ca snt colloid papillary hyperplasia iso iso no hetero irr fine no 
161. ezhilarasi 23 f 21577 thyroiditis thyroiditis colloid thyroiditis hetero hetero no no no bbn 
162. dhanalakshmi 37 f 22805 colloid mng colloid colloid iso iso cystic reg cystic reg no no 
163. asha 37 f 22791 adenoma mng colloid adenoma iso iso hypo reg hetero reg coarse no 
164. kamaraj 42 m 22948 pap ca pap ca colloid pap ca iso iso hypo reg hypo irr fine coarse no 
165. shanthi 36 f 23934 pap ca mng papillary hyperplasia 
papillary 
hyperplasia iso iso hetero reg hetero reg fine coarse no 
166. prema 45 f 23913 pap ca mng colloid adenoma iso iso no hetero reg coarse no 
167. murugammal 36 f 23950 colloid colloid colloid colloid iso iso cystic reg cystic reg coarse no 
168. adhilakshmi 35 f 25115 thyroiditis mng colloid thyroiditis hypo hypo iso halo no no no 
169. usharani 48 f 25098 colloid colloid colloid colloid hypo hypo iso reg iso reg no no 
170. visalam 42 f 26175 pap ca pap ca colloid pap ca iso iso hypo irr hypo irr fine no 
171. subashini 32 f 27357 thyroiditis colloid pap ca thyroiditis hetero hetero hypo reg hypo reg coarse no 
172. chandra 65 f 27406 colloid colloid colloid thyroiditis iso iso iso halo hypo reg coarse no 
173. selvi 25 f 27400 thyroiditis mng thyroiditis thyroiditis hypo hypo iso reg iso hypo no no 
174. selvanayagi 24 f 28374 adenoma mng follicular 
neoplasm adenoma iso hetero no iso halo no no 
175. dhanalakshmi 27 f 30472 pap ca colloid thyroiditis pap ca iso iso hetero reg hypo reg fine rt bn 
176. vijaya 35 f 30465 thyroiditis mng papillary hyperplasia thyroiditis hetero hetero no no no no 
177. janaki 45 f 30470 thyroiditis thyroiditis thyroiditis thyroiditis hetero hypo hypo reg no eggshell no 
178. maheswari 58 f 30488 adenoma colloid thyroiditis thyroiditis hypo hypo no iso halo coarse no 
179. sampath 48 m 30473 pap ca colloid pap ca pap ca iso iso hetero irr hetero irr fine coarse no 
180. gowthami 19 f 30474 colloid colloid pap ca adenoma iso iso cystic reg no no no 
181. kasi 67 m 31556 pap ca mng colloid pap ca iso iso hetero irr hetero irr fine comet bbn 
182. hemalatha 30 f 31554 adenoma mng colloid colloid iso iso hypo reg iso halo coarse no 
  
183. easwari 38 f 31565 pap ca snt papillary hyperplasia pap ca iso iso no hypo irr coarse no 
184. devaraj 33 m 31864 med ca mets med ca mets med ca mets med ca mets absent iso no no no bmn 
185. gunasundari 25 f 33357 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no hyper reg no no 
186. shanthi 42 f 33445 pap ca colloid colloid pap ca iso iso no hetero reg eggshell no 
187. anjalai 40 f 33479 pap ca colloid pap ca pap ca iso iso no hypo irr no no 
188. prem kumar 53 m 35694 colloid colloid colloid colloid iso iso iso reg iso reg no no 
189. arunachalam 56 m 33457 thyroiditis snt colloid colloid hypo iso no hetero reg coarse no 
190. lalithakumari 19 f 34580 thyroiditis colloid colloid thyroiditis hypo iso hyper reg hypo reg no no 
191. deepa 30 f 34609 thyroiditis colloid colloid thyroiditis hypo hypo hetero reg hetero reg comet no 
192. sasikala 42 f 34621 thyroiditis thyroiditis colloid thyroiditis hypo hypo iso halo hypo reg no no 
193. jayanthi 28 f 35805 pap ca pap ca pap ca pap ca iso iso no hetero reg fine no 
194. lavanya 37 f 38360 colloid colloid colloid colloid iso iso iso reg hypo reg no no 
195. jayalakshmi 27 f 35798 pap ca pap ca pap ca pap ca iso hypo no hetero irr fine lt bn 
196. dhanalakshmi 41 f 36934 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no hypo no no 
197. saraswathy 65 f 36870 pap ca pap ca pap ca pap ca iso iso hetero irr hypo irr fine coarse bmn 
198. lakshmi 38 f 37955 colloid colloid colloid colloid iso iso cystic no coarse no 
199. devi 28 f 37958 thyroiditis thyroiditis colloid thyroiditis hypo hypo no no no no 
200. thayarammal 40 f 37937 colloid colloid colloid colloid iso iso hypo reg hetero reg comet coarse no 
201. geetha 46 f 39093 colloid colloid colloid colloid iso iso iso halo hypo reg coarse no 
202. rajkumar 16 m 36869 colloid colloid thyroiditis colloid absent hypo no no no no 
203. hemalatha 30 f 31554 colloid colloid colloid colloid iso iso iso reg no no no 
204. lakshmanan 28 m 39069 thyroiditis colloid colloid colloid iso hypo hetero reg no coarse no 
205. mary clara 28 f 40199 pap ca mng adenoma pap ca iso iso hypo irr no coarse no 
206. mujibunnisa 21 f 40171 colloid mng colloid colloid iso iso hetero reg no comet coarse no 
207. jaya 46 f 40236 adenoma mng colloid adenoma iso iso hetero reg iso halo no lt bn 
208. nirmala 28 f 40234 colloid colloid colloid colloid iso iso hypo reg hypo reg no bbn 
209. naji 30 f 40228 colloid colloid colloid colloid iso iso hetero reg no comet no 
210. amudha 45 f 40245 colloid colloid colloid colloid iso iso cystic irr no coarse rt bn 
211. chowdamma 20 f 40345 colloid colloid colloid colloid iso iso hypo reg hypo reg coarse no 
212. rajendran 48 m 40367 colloid colloid colloid colloid iso hypo hetero reg hypo reg coarse no 
213. vijaya 35 f 40260 thyroiditis mng colloid colloid absent hypo no hetero reg coarse no 
214. devi 55 f 41325 pap ca snt colloid pap ca iso iso hetero irr no fine coarse no 
215. prabha 32 f 43654 thyroiditis mng colloid thyroiditis iso iso hypo reg hetero reg coarse com no 
  
216. kiruthiga 11 f 43636 pap ca pap ca pap ca pap ca iso iso hetero irr no fine coarse bil mn 
217. rajeswari 37 f 43651 pap ca colloid colloid papillary hyperplasia iso iso hetero irr hypo reg fine coarse 
rt mn lt 
bn 
218. navaneetham 34 f 43653 adenoma colloid thyroiditis adenoma iso iso heter reg iso halo comet bbn 
219. maheswari 30 f 42594 med ca mets med ca mets med ca mets med ca mets absent absent no no no lt mn 
220. angappa reddy 65 m 42506 colloid colloid colloid pap ca iso iso hetero reg cystic irr comet coarse bbn 
221. amudha 45 f 40245 colloid snt colloid colloid iso iso cystic irr no coarse rt bn 
222. sakunthala 34 f 42451 adenoma adenoma colloid colloid iso iso hypo halo no coarse no 
223. mohana 22 f 42473 colloid snt colloid colloid iso iso cystic reg no coarse no 
224. lakshmi 22 f 43892 colloid colloid colloid colloid iso iso iso reg iso reg no no 
225. kasthuri 38 f 42487 colloid colloid colloid colloid iso iso cystic reg iso halo coarse rt bn 
226. priyanka 17 f 44812 colloid snt colloid thyroiditis iso iso no cystic reg coarse lt bn 
227. sampathammal 50 f 44857 colloid colloid pap ca colloid iso iso hetero reg iso halo coarse no 
228. selvi 26 f 45938 colloid mng colloid colloid iso iso hypo reg hypo reg no no 
229. muniammal 46 f 45960 thyroiditis colloid colloid thyroiditis iso hypo hypo reg no no no 
230. padmavathy 43 f 45941 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no no no no 
231. lakshmi 32 f 45890 pap ca pap ca pap ca pap ca iso iso iso hypo reg fine coarse egg 
shell no 
232. fathimuthu 30 f 47262 pap ca pap ca pap ca pap ca iso iso hetero irr no fine coarse rt bn 
233. kalyani 32 f 47113 pap ca pap ca pap ca pap ca iso iso no hypo reg fine coarse lt mn 
234. kasthuri 38 f 42487 colloid adenoma colloid colloid hypo iso no hetero irr eggshell no 
235. swarnalatha 28 f 49562 colloid colloid colloid colloid iso iso cystic reg cystic reg no no 
236. razia begum 40 f 49484 thyroiditis colloid colloid thyroiditis hypo iso cystic reg iso reg no rt bn 
237. brindala 23 f 49519 adenoma mng papillary hyperplasia adenoma iso iso iso reg iso reg comet coarse rt bn 
238. patchaiammal 38 f 47158 colloid colloid colloid colloid iso iso cystic irr cystic reg no no 
239. meera 55 f 48219 colloid snt colloid adenoma iso iso cystic irr no no bbn 
240. angel mary 45 f 48273 colloid colloid colloid colloid iso iso iso reg cystic reg comet coarse no 
241. pushpa 75 f 49472 pap ca pap ca pap ca pap ca iso iso hypo no fine no 
242. palani 40 m 43599 med ca med ca med ca med ca hypo iso hypo irr hypo reg coarse rt mn 
243. govindammal 65 f 48646 pap ca pap ca pap ca pap ca iso iso hetero irr hetero irr fine coarse bbn 
244. sasikala 30 f 50696 pap ca colloid colloid pap ca iso iso hypo reg hypo irr coarse rt bn 
245. mahalakshmi 56 f 50670 thyroiditis thyroiditis colloid thyroiditis hetero hetero hetero reg hetero reg comet coarse bbn 
246. chellaiah 70 m 50638 pap ca pap ca pap ca papillary iso iso hypo reg hetero irr fine coarse lt mn rt 
  
hyperplasia bn 
247. ramachandran 38 m 44824 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero hypo irr hypo irr comet bbn 
248. ashokkumar 21 m 50660 colloid colloid colloid colloid absent hypo no no coarse no 
249. mani 51 m 51893 thyroiditis thyroiditis colloid thyroiditis hypo hypo no no no no 
250. deepan kumar 26 m 51962 colloid snt colloid colloid iso hetero hetero reg no coarse no 
251. tamilarasi 46 f 53106 colloid colloid colloid thyroiditis iso iso no hypo reg no no 
252. anbarasi 38 f 53076 colloid colloid colloid colloid iso iso no hetero reg 
sep coarse no 
253. pavai 42 f 51906 pap ca colloid colloid pap ca iso hetero hypo irr no fine no 
254. tamil selvi 28 f 51900 thyroiditis mng colloid thyroiditis hetero hetero hetero reg hetero irr coarse bbn 
255. poornima 20 f 53077 pap ca snt colloid pap ca iso iso hetero irr no fine coarse rt bn 
256. nirmala 52 f 54344 colloid colloid colloid colloid iso iso hetero reg cystic irr comet coarse no 
257. yashodha 36 f 55467 pap ca mng colloid pap ca iso iso hypo reg iso reg fine no 
258. sakunthala 52 f 55494 pap ca colloid colloid pap ca hetero hetero iso reg hetero reg fine coarse no 
259. vanitha 35 f 55456 adenoma adenoma colloid adenoma iso iso hypo halo no coarse bbn 
260. renuka 32 f 55451 colloid colloid colloid colloid hetero hetero no hypo reg coarse no 
261. gomathi 28 f 55435 colloid colloid colloid colloid iso iso iso halo iso halo no no 
262. sangeetha 32 f 59011 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero hetero reg hetro reg no bbn 
263. indrani 36 f 56692 pap ca pap ca colloid pap ca iso hetero hetero irr hypo reg fine coarse no 
264. padmavathy 30 f 56706 thyroiditis thyroiditis colloid thyroiditis hypo hetero no no no bbn 
265. vijayalaxmi 40 f 58970 thyroiditis mng thyroiditis thyroiditis hetero hypo no no no rt bn 
266. malliga 35 f 58976 colloid colloid colloid colloid iso iso cystic reg cystic reg comet coarse no 
267. uma maheswari 48 f 60152 thyroiditis colloid colloid thyroiditis hetero iso cystic reg cystic reg no bbn 
268. sarasu 44 f 60162 colloid colloid colloid adenoma iso iso no cystic irr coarse com lt bn 
269. shanthi 43 f 60161 colloid colloid colloid colloid hetero hetero hypo reg cystic irr comet bbn 
270. shanthi 45 f 39088 pap ca mng colloid pap ca iso iso hypo reg hypo irr fine no 
271. jasmine 34 f 61416 thyroiditis snt thyroiditis pap ca iso hetero hypo reg no no no 
272. kanagavalli 55 f 61422 colloid colloid colloid adenoma iso iso no cystic reg comet no 
273. saraswathy 23 f 61437 pap ca mng pap ca pap ca iso iso cystic hypo reg fine comet no 
274. saroja 45 f 61335 colloid colloid colloid colloid iso iso no hypo reg no no 
275. sumathy 37 f 60140 colloid pap ca thyroiditis pap ca iso iso no cystic reg no lt bn 
276. revathy 50 f 61427 adenoma mng colloid thyroiditis iso iso iso reg hypo halo no bbn 
277. vaidehi 20 f 69775 adenoma mng colloid colloid iso iso hypo hypo halo no no 
278. estherrani 15 f 68758 colloid colloid thyroiditis colloid absent iso no no no no 
  
279. jayanthi 35 f 67358 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
280. vennila 28 f 63245 pap ca pap ca colloid pap ca iso iso hypo irr heter irr fine rt mn 
281. revathy 50 f 61427 thyroiditis mng colloid thyroiditis hetero hetero hypo reg hypo reg no no 
282. vijaya 38 f 61527 thyroiditis thyroiditis colloid colloid hypo hypo no no no no 
283. devi 28 f 62627 colloid mng colloid colloid iso iso hypo reg no no no 
284. jamuna 35 f 75444 thyroiditis colloid thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
285. priya 31 f 63730 pap ca colloid colloid pap ca iso iso no hetero irr fine no 
286. kasthuri 32 f              49471 pap ca adenoma colloid pap ca iso iso hypo reg heter irr fine coarse no 
287. vadivel 55 m 64681 adenoma colloid colloid adenoma iso iso iso halo hypo reg no no 
288. vijayalaxmi 35 f 75479 colloid pap ca colloid colloid iso hypo cystic irr no coarse bbn 
289. poongothai 23 f 69818 adenoma colloid colloid papillary hyperplasia hetero iso no iso halo comet coarse no 
290. ambika 44 f 72174 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg iso reg no no 
291. malathy 48 f 74290 thyroiditis colloid colloid colloid iso hypo cystic irr no no no 
292. nirmala 50 f 74274 pap ca colloid colloid pap ca hetero hypo hetero reg hetero irr coarse no 
293. saraswathy 34 f 73212 thyroiditis thyroiditis thyroiditis thyroiditis iso hypo no no coarse no 
294. ezhumalai 60 m 68615 colloid pap ca pap ca colloid iso hypo no iso reg no no 
295. daisy 37 f 77685 colloid colloid colloid colloid iso iso hypo halo no no no 
296. sumathy 27 f 68580 pap ca pap ca colloid pap ca iso iso no hetero irr fine coarse lt bn 
297. kamatchi 55 f 77672 pap ca mng colloid pap ca iso iso cystic reg hetero irr fine coarse no 
298. kittappa 37 m 74276 pap ca colloid colloid papillary hyperplasia iso iso hetero reg hetero irr coarse ltbn 
299. sivakumar 27 m 74265  thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso iso no no 
300. jayamary 55 f 84500 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero heter reg hypo halo no bbn 
301. saroja 65 f 84518 pap ca pap ca colloid pap ca iso iso hypo irr hypo reg fine coarse rt mn 
302. chamundeswari 22 f 84535 colloid pap ca colloid colloid iso iso no cystic reg no lt bn 
303. kuttimma 35 f 84559 colloid colloid colloid colloid iso iso hypo reg hypo reg coarse no 
304. suryakala 45 f 79850 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo iso reg hyper reg coarse no 
305. thillaivanam 45 f 85706 colloid colloid colloid colloid iso iso hypo reg cystic irr comet coarse no 
306. chandra 50 f 83341 pap ca colloid colloid pap ca iso iso no hypo irr coarse no 
307. uma 23 f 80960 thyroiditis colloid colloid colloid hetero hetero no hypo reg no no 
308. parvathy 57 f 79823 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no no no bbn 
309. kasthuri 50 f 85702 adenoma mng follicular adenoma iso iso hypo halo no coarse no 
  
neoplasm 
310. dhanapal 75 m 63875 pap ca pap ca colloid pap ca iso iso hypo irr hetero irr fine coarse no 
311. rajakumari 45 f 86816 colloid colloid colloid adenoma iso iso cystic reg no comet no 
312. jayalakshmi 50 f 86883 thyroiditis mng colloid thyroiditis hypo hetero iso hypo reg no no 
313. valliammal 60 f 80915 pap ca mng colloid pap ca iso hypo no no fine lt mn 
314. thangam 32 f 84585 thyroiditis mng thyroiditis thyroiditis hypo hypo no iso reg coarse no 
315. surya 23 f 87375 colloid pap ca colloid pap ca iso iso cystic reg no coarse no 
316. deepa 19 f 86701 colloid pap ca colloid thyroiditis iso iso cystic reg no no no 
317. saranyan 16 m 45995 colloid colloid colloid colloid iso iso iso reg iso reg no lt bn 
318. kanchana 29 f 89706 thyroiditis colloid colloid colloid hypo iso cystic reg no coarse no 
319. uma maheswari 40 f 89039 pap ca mets pap ca mets pap ca mets pap ca mets iso iso no hetero irr fine coarse rt bn lt 
mn 
320. prathiba 32 f 88010 colloid mng colloid colloid iso iso hypo reg cystic reg comet coarse lt bn 
321. dhanasekar 42 m 87985 thyroiditis thyroiditis pap ca thyroiditis iso hypo no iso reg no lt bn 
322. sheela 32 f 91350 pap ca pap ca pap ca pap ca iso iso no hetero irr coarse lt mn 
323. vedamma 40 f 91305 colloid colloid colloid colloid iso iso cystic reg no comet no 
324. ilanjiyam 45 f 91302 colloid snt pap ca colloid iso iso hypo reg no coarse no 
325. arpudham 38 f 88214 pap ca pap ca pap ca pap ca iso iso no hetero irr fine coarse rt bn lt 
mn 
326. sivagami 39 f 87960 colloid adenoma colloid colloid iso iso cystic reg hetero reg comet coarse lt bn 
327. angammal 45 f 94563 colloid mng colloid colloid iso iso iso reg cystic reg comet coarse rt bn rt bn 
328. parimala 40 f 99479 colloid colloid colloid colloid iso iso no cystic reg no bbn 
329. pramila 45 f 99721 colloid colloid colloid colloid iso iso no cystic reg no no 
330. manjula 22 f 94486 adenoma colloid colloid adenoma iso iso no hypo reg coarse no 
331. thilagam 39 f 97512 adenoma mng colloid adenoma hypo iso iso halo hypo reg no no 
332. balammal 60 f 97048 thyroiditis thyroiditis thyroiditis thyroiditis hypo hypo no iso reg no no 
333. anwar basha 27 m 98690 pap ca adenoma colloid pap ca iso iso hetero irr no fine coarse no 
334. govindan 32 m 98717 adenoma adenoma thyroiditis colloid iso iso no iso reg no no 
335. vijayalaxmi 34 f 98684 adenoma snt thyroiditis adenoma iso iso hypo halo no coarse no 
336. rajeswari 55 f 104676 pap ca mng colloid pap ca iso iso hypo reg hetero irr fine coarse no 
337. thangammal 62 f 103458 colloid colloid colloid adenoma iso iso iso reg hypo reg no no 
338. vijaya 40 f 102293 thyroiditis thyroiditis thyroiditis thyroiditis hetero hetero no no no no 
339. chellammal 65 f 104567 colloid colloid colloid colloid hypo hypo no cystic reg no no 
  
340. mobishara begum 19 f 
102406                 
pap ca pap ca pap ca pap ca pap ca iso iso hypo hetero hypo reg fine coarse rt bn 
341. navaladi 40 m 104552 pap ca pap ca pap ca pap ca iso iso hypo irr hypo reg fine coarse bbn 
342. sekar 51 m 86048 pap ca mets pap ca mets pap ca mets pap ca mets iso hypo hypo reg hetero irr fine coarse lt mn 
343. pattu 70 f 111171 pap ca pap ca pap ca pap ca iso iso hypo irr no fine no 
344. mohana 45 f 101019 pap ca mng thyroiditis pap ca hypo iso iso reg hetero irr fine coarse no 
345. amudhavani 46 f 100942 colloid colloid pap ca colloid iso iso iso halo cystic reg no no 
346. radha 54 f 102340 thyroiditis thyroiditis colloid colloid iso iso hetero reg hetero reg comet coarse lt bn 
347. chellammal 65 f 104567 colloid mng colloid colloid iso hypo iso reg cystic reg no no 
348. subramani 53 m 107790 pap ca mng pap ca pap ca iso iso hetero irr hypo reg fine rt mn 
349. kamala 65 f 108973 pap ca pap ca thyroiditis pap ca iso iso hypo reg hetero irr fine coarse bbn 
350. habeeba 28 f 85097 pap ca mets pap ca mets pap ca mets reactive 


























Cystic nodules without internal 
echogenic foci 
 Large predominantly cystic 
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Hypoechoic nodule with 
echogenic foci 



















Refractive shadow from the edge 
of the lesion 
































Hypoechoic nodule with fine 
calcifications 



















Level 3 Node with calcifications  Cystic node 
 
 
